vignette,question_1,question_2,question_3,question_4,question_5,answer_1,answer_2,answer_3,answer_4,answer_5,marks_1,marks_2,marks_3,marks_4,marks_5,Total_Marks_Achieved
" History of Present Illness
A 58-year-old male presents with a 3-week history of gradually worsening fatigue, weight loss, and fever. Over the past week, he has developed pain and redness in his right hand, which has been intermittently swollen. He denies trauma or any recent infections. He also reports having had bilateral leg pain that worsens with activity but improves with rest. The patient has no history of similar symptoms. He has not been on any new medications, and he denies smoking or alcohol use. His family history is notable for autoimmune diseases, as his father has rheumatoid arthritis. 

  Past Medical History
The patient has a history of hypertension for 10 years, managed with an ACE inhibitor. He has no known history of autoimmune diseases or vasculitis. He underwent a cholecystectomy 5 years ago . 

  Physical Examination
VITALS: BP 135/85 mmHg, pulse 88 bpm, temperature 100.4°F. 
GEN: Ill-appearing, mildly febrile, visibly fatigued. 
CARDIAC: Regular rhythm, no murmurs, Feeble peripheral pulses 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: Swelling and erythema of the right hand with tenderness to palpation at the metacarpophalangeal joint. Bilateral calf tenderness with no signs of deep venous thrombosis. 
EXT: No edema, but marked tenderness in the lower extremities. 
SKIN: Petechial rash over the anterior shin. 

  Laboratory Results
WBC: 12 x 103 cells/μL (elevated). Hemoglobin: 11.8 g/dL. ESR: 65 mm/h (elevated). Positive anti-ds DNA antibodies. CRP: 45 mg/L (elevated). Urinalysis: 2+ protein, no blood. Creatinine: 1.2 mg/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Systemic Lupus Erythematosus (SLE)**: The patient's symptoms such as fever, fatigue, weight loss, joint pain, and swelling, along with laboratory results like elevated ESR, CRP, and positive anti-ds DNA antibodies, are consistent with SLE. The presence of proteinuria also supports this diagnosis.
2. **Rheumatoid Arthritis (RA)**: The patient's symptoms like joint pain, swelling, and tenderness, particularly in the hands and feet, are similar to those seen in RA. The family history of RA also increases the likelihood of this diagnosis. However, the presence of systemic symptoms like fever and weight loss, and laboratory results like elevated ESR and CRP, suggest that the diagnosis might be more complex.
3. **Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**: The patient's symptoms like fever, weight loss, and fatigue, along with laboratory results like elevated ESR and CRP, could suggest a vasculitic process. The presence of petechial rash and tenderness in the lower extremities also supports this diagnosis. However, the absence of other typical symptoms like headache, jaw claudication, or visual disturbances makes this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Systemic Lupus Erythematosus (SLE)**

Supporting findings and risk factors:

* Positive anti-ds DNA antibodies: a specific autoantibody commonly found in SLE patients
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate active inflammation, which is a hallmark of SLE
* Proteinuria (2+ protein on urinalysis): suggests renal involvement, which is common in SLE
* Fever, fatigue, and weight loss: systemic symptoms that are often seen in SLE
* Joint pain and swelling, particularly in the hands: SLE can cause arthritis and arthralgias
* Family history of autoimmune diseases (father with rheumatoid arthritis): increases the risk of developing an autoimmune disease like SLE
* Petechial rash: a common skin manifestation of SLE

**2. Rheumatoid Arthritis (RA)**

Supporting findings and risk factors:

* Joint pain and swelling, particularly in the hands (metacarpophalangeal joint tenderness): consistent with RA
* Bilateral calf tenderness: suggests symmetric polyarthritis, which is typical of RA
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate active inflammation, which is common in RA
* Family history of RA (father with RA): increases the risk of developing RA
* Morning stiffness and worsening of symptoms with activity: although not explicitly mentioned, these are common symptoms of RA
* Absence of other systemic symptoms like fever and weight loss: RA is often characterized by joint-specific symptoms, although some patients may experience systemic symptoms

**3. Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**

Supporting findings and risk factors:

* Fever, weight loss, and fatigue: systemic symptoms that can occur in vasculitis
* Petechial rash: a common skin manifestation of vasculitis
* Tenderness in the lower extremities: suggests peripheral vasculitis
* Elevated ESR (65 mm/h) and CRP (45 mg/L): indicate active inflammation, which is common in vasculitis
* Absence of other typical symptoms like headache, jaw claudication, or visual disturbances: makes Giant Cell Arteritis less likely, but Polyarteritis Nodosa or other forms of vasculitis are still possible
* Feeble peripheral pulses: suggests vascular involvement, which is consistent with vasculitis

Note that these findings and risk factors are not mutually exclusive, and some may overlap between diagnoses. A definitive diagnosis will require further evaluation and testing.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Systemic Lupus Erythematosus (SLE)**

Opposing findings:

* Absence of other specific autoantibodies like anti-Sm or anti-RNP: while anti-ds DNA antibodies are present, the absence of other specific autoantibodies is notable
* No mention of photosensitivity, oral ulcers, or alopecia: these are common symptoms of SLE, but they are not reported in this patient
* Normal urinalysis except for proteinuria: SLE often causes more significant renal involvement, including hematuria, casts, or nephrotic syndrome
* No mention of neurological or psychiatric symptoms: SLE can cause a range of neurological and psychiatric symptoms, including seizures, psychosis, or cognitive impairment
* Absence of malar rash or discoid rash: these are classic skin manifestations of SLE, but they are not reported in this patient

Expected findings that are not present:

* Low complement levels (C3, C4): SLE often causes low complement levels, but they are not reported in this patient
* Presence of other autoantibodies like anti-SSA/Ro or anti-SSB/La: these autoantibodies are commonly found in SLE patients, but they are not mentioned in this case

**2. Rheumatoid Arthritis (RA)**

Opposing findings:

* Presence of systemic symptoms like fever, weight loss, and fatigue: RA is often characterized by joint-specific symptoms, and systemic symptoms are less common
* Elevated ESR and CRP: while these inflammatory markers are elevated, they are not as high as might be expected in a patient with active RA
* Absence of morning stiffness or worsening of symptoms with rest: these are common symptoms of RA, but they are not reported in this patient
* Presence of petechial rash: this is not a typical skin manifestation of RA
* Absence of nodules or deformities: RA often causes joint deformities or nodules, but they are not mentioned in this patient

Expected findings that are not present:

* Presence of rheumatoid factor (RF) or anti-CCP antibodies: these autoantibodies are commonly found in RA patients, but they are not reported in this case
* More significant joint involvement: RA often causes symmetric polyarthritis, but the joint involvement in this patient is relatively limited

**3. Vasculitis (e.g., Polyarteritis Nodosa or Giant Cell Arteritis)**

Opposing findings:

* Absence of other typical symptoms like headache, jaw claudication, or visual disturbances: these symptoms are commonly seen in Giant Cell Arteritis, but they are not reported in this patient
* No mention of abdominal pain or gastrointestinal symptoms: Polyarteritis Nodosa often causes abdominal pain or gastrointestinal symptoms, but they are not reported in this patient
* Absence of neuropathy or mononeuritis multiplex: vasculitis can cause neuropathy or mononeuritis multiplex, but these symptoms are not mentioned in this patient
* Normal urinalysis except for proteinuria: vasculitis can cause more significant renal involvement, including hematuria or nephrotic syndrome

Expected findings that are not present:

* Presence of anemia or leukocytosis: vasculitis can cause anemia or leukocytosis, but they are not reported in this patient
* Elevated liver enzymes or abnormal liver function tests: vasculitis can cause liver involvement, but liver function tests are not mentioned in this case
* Presence of other autoantibodies like ANCA: these autoantibodies are commonly found in certain types of vasculitis, but they are not reported in this patient","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Systemic Lupus Erythematosus (SLE)**

The diagnosis of SLE is supported by the presence of:

* Positive anti-ds DNA antibodies, which are a specific autoantibody commonly found in SLE patients
* Elevated ESR and CRP, which indicate active inflammation
* Proteinuria, which suggests renal involvement
* Fever, fatigue, and weight loss, which are systemic symptoms commonly seen in SLE
* Joint pain and swelling, particularly in the hands, which is consistent with SLE
* Petechial rash, which is a common skin manifestation of SLE
* Family history of autoimmune diseases, which increases the risk of developing SLE

While the patient's symptoms and laboratory results could also be consistent with other diagnoses, such as rheumatoid arthritis or vasculitis, the presence of positive anti-ds DNA antibodies and the combination of systemic and joint symptoms make SLE the most likely diagnosis.

**Classification criteria:**

The patient meets the 1997 American College of Rheumatology (ACR) classification criteria for SLE, which include:

* Positive anti-ds DNA antibodies
* Proteinuria
* Joint pain and swelling
* Fever
* Fatigue
* Weight loss

The patient also meets the 2012 Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for SLE, which include:

* Positive anti-ds DNA antibodies
* Proteinuria
* Joint pain and swelling
* Fever
* Fatigue
* Weight loss
* Petechial rash

**Next steps:**

The patient should undergo further evaluation and testing to confirm the diagnosis and assess the extent of disease activity. This may include:

* Repeat laboratory tests to confirm the presence of anti-ds DNA antibodies and to assess the level of inflammation
* Urine protein-to-creatinine ratio to assess the severity of proteinuria
* Renal biopsy to assess the extent of renal involvement
* Imaging studies, such as chest X-ray or abdominal ultrasound, to assess for other organ involvement
* Consultation with a rheumatologist to discuss treatment options and develop a management plan.","Based on the diagnosis of Systemic Lupus Erythematosus (SLE), the following additional steps should be taken:

**Immediate steps:**

1. **Initiate treatment:** Start the patient on a course of corticosteroids, such as prednisone, to reduce inflammation and suppress the immune system.
2. **Monitor vital signs:** Closely monitor the patient's vital signs, including blood pressure, pulse, and temperature, to ensure that they are stable.
3. **Assess for organ involvement:** Perform a thorough physical examination and review the patient's medical history to assess for any signs of organ involvement, such as renal disease, cardiovascular disease, or neurological disease.

**Short-term steps:**

1. **Order additional laboratory tests:** Order additional laboratory tests, such as:
	* Complete blood count (CBC) to assess for anemia, leukopenia, or thrombocytopenia.
	* Blood chemistry tests, such as liver function tests and electrolyte panels, to assess for any abnormalities.
	* Urine tests, such as a urinalysis and urine protein-to-creatinine ratio, to assess for renal involvement.
2. **Imaging studies:** Order imaging studies, such as:
	* Chest X-ray to assess for pulmonary involvement.
	* Abdominal ultrasound to assess for renal involvement.
	* Echocardiogram to assess for cardiac involvement.
3. **Consultations:** Consult with other specialists, such as:
	* Nephrologist to assess for renal involvement and develop a plan for managing renal disease.
	* Cardiologist to assess for cardiac involvement and develop a plan for managing cardiac disease.
	* Neurologist to assess for neurological involvement and develop a plan for managing neurological disease.

**Long-term steps:**

1. **Develop a treatment plan:** Develop a comprehensive treatment plan that includes:
	* Medications, such as corticosteroids, immunosuppressants, and anti-inflammatory medications.
	* Lifestyle modifications, such as stress reduction, exercise, and dietary changes.
	* Regular follow-up appointments to monitor disease activity and adjust the treatment plan as needed.
2. **Monitor disease activity:** Regularly monitor the patient's disease activity using:
	* Laboratory tests, such as CBC, blood chemistry tests, and urine tests.
	* Imaging studies, such as chest X-ray and abdominal ultrasound.
	* Clinical assessments, such as physical examination and review of symptoms.
3. **Prevent complications:** Take steps to prevent complications, such as:
	* Osteoporosis prevention, such as calcium and vitamin D supplements.
	* Cardiovascular disease prevention, such as statins and blood pressure management.
	* Infection prevention, such as vaccinations and prophylactic antibiotics.

**Patient education:**

1. **Disease education:** Educate the patient about SLE, including its causes, symptoms, and treatment options.
2. **Medication education:** Educate the patient about their medications, including their purpose, dosage, and potential side effects.
3. **Lifestyle modifications:** Educate the patient about lifestyle modifications, such as stress reduction, exercise, and dietary changes, that can help manage their disease.
4. **Follow-up appointments:** Emphasize the importance of regular follow-up appointments to monitor disease activity and adjust the treatment plan as needed.","{""Score"":3,""Rationale"":""The answer includes Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Vasculitis (e.g., Polyarteritis Nodosa), all of which are listed in the high‑scoring example. Each matches a rubric concept, earning the full 3 points.""}","{""Score"":6,""Rationale"":""The answer correctly identified and described the three diagnoses highlighted in the rubric—Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Vasculitis—providing the specific findings listed in the high‑scoring example for each. No points were deducted as the required concepts were all present.""}","{""Score"":6,""Rationale"":""The answer lists opposing findings that correspond to the rubric’s key concepts: for SLE it notes absence of renal involvement and butterfly rash; for RA it notes absence of morning stiffness and joint deformities; for Vasculitis it notes lack of clear systemic vessel involvement and related symptoms. All three required concepts are present, earning the full 6 points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Systemic Lupus Erythematosus (SLE) and lists the key clinical findings—fever, weight loss, elevated ESR/CRP, arthritis/joint pain, rash, and proteinuria—that match the high‑scoring example, thus earning full credit.""}","{""Score"":0,""Rationale"":""The answer does not include any of the three rubric concepts: referral to a rheumatologist, kidney biopsy for persistent proteinuria, or initiation of hydroxychloroquine. Hence no points are awarded.""}",17.0
"History of Present Illness 
A 58-year-old male presents with a 6-month history of progressive fatigue, weight loss, and peripheral edema. He also reports shortness of breath on exertion and difficulty swallowing solid foods for the past 2 months. His urine has become frothy, and he has noticed some tingling sensations in his hands. He denies chest pain, fever, or night sweats. There is no history of hypertension, diabetes, or known heart disease. 
Past Medical History 
The patient has a 10-year history of rheumatoid arthritis, well-controlled with methotrexate. He denies smoking or alcohol use. Family history is negative for any genetic disorders. 
Physical Examination 
VITALS: BP 110/70 mmHg, pulse 90/min, temperature 98.4°F. 
GEN: Thin, pale, fatigued. 
CARDIAC: No murmurs, but there is a slight periorbital edema. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild hepatomegaly (2 cm below the costal margin), no tenderness. 
EXT: Bilateral pedal edema, no erythema or ulcers. 
NEURO: Decreased sensation to light touch in both feet, absent ankle reflexes. 

Laboratory Results
Urinalysis shows 2+ proteinuria, and serum creatinine is 1.5 mg/dL. The BNP is elevated at 550 pg/mL. Serum free light chains are elevated, and a biopsy of abdominal fat reveals amyloid deposits. Echocardiogram shows concentric left ventricular hypertrophy with normal systolic function. Hemoglobin levels within normal range.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Amyloid Light-Chain (AL) Amyloidosis**: The presence of elevated serum free light chains, proteinuria, and amyloid deposits in the abdominal fat biopsy strongly suggest AL amyloidosis. The patient's symptoms, such as fatigue, weight loss, and peripheral edema, are also consistent with this diagnosis.
2. **Cardiac Amyloidosis**: The patient's symptoms of shortness of breath on exertion, difficulty swallowing, and periorbital edema, along with the elevated BNP and concentric left ventricular hypertrophy on echocardiogram, suggest cardiac involvement. Cardiac amyloidosis can lead to restrictive cardiomyopathy, which may explain the patient's symptoms.
3. **Systemic Amyloidosis with Renal Involvement**: The patient's proteinuria, elevated serum creatinine, and mild hepatomegaly suggest renal involvement. The presence of amyloid deposits in the abdominal fat biopsy and elevated serum free light chains also support this diagnosis. Systemic amyloidosis can affect multiple organs, including the kidneys, heart, and nerves, which is consistent with the patient's symptoms and laboratory findings.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Elevated serum free light chains**: This is a key diagnostic criterion for AL amyloidosis, as it indicates the presence of a monoclonal protein that can deposit as amyloid fibrils in tissues.
* **Amyloid deposits in abdominal fat biopsy**: The presence of amyloid deposits in the biopsy is a definitive diagnostic finding for amyloidosis.
* **Proteinuria**: AL amyloidosis can cause renal involvement, leading to proteinuria, which is present in this patient (2+ proteinuria).
* **History of rheumatoid arthritis**: While not a direct risk factor, rheumatoid arthritis can increase the risk of developing a monoclonal gammopathy, which can progress to AL amyloidosis.
* **Weight loss and fatigue**: These are common symptoms of AL amyloidosis, which can occur due to the deposition of amyloid fibrils in various tissues.

**2. Cardiac Amyloidosis**

* **Elevated BNP**: An elevated BNP level is a marker of cardiac stress and is often elevated in patients with cardiac amyloidosis.
* **Concentric left ventricular hypertrophy on echocardiogram**: This is a characteristic finding in cardiac amyloidosis, which can lead to restrictive cardiomyopathy.
* **Shortness of breath on exertion**: This symptom is consistent with cardiac amyloidosis, which can impair cardiac function and lead to exertional dyspnea.
* **Periorbital edema**: This finding can be seen in cardiac amyloidosis, which can cause fluid overload and edema.
* **Absence of hypertension or known heart disease**: The absence of these risk factors makes cardiac amyloidosis a more likely diagnosis, as it can occur in the absence of traditional cardiovascular risk factors.

**3. Systemic Amyloidosis with Renal Involvement**

* **Proteinuria**: The presence of 2+ proteinuria suggests renal involvement, which is a common feature of systemic amyloidosis.
* **Elevated serum creatinine**: This finding indicates impaired renal function, which can occur in systemic amyloidosis with renal involvement.
* **Mild hepatomegaly**: This finding can be seen in systemic amyloidosis, which can cause hepatic involvement and lead to hepatomegaly.
* **Peripheral edema**: This symptom can occur in systemic amyloidosis with renal involvement, which can cause fluid overload and edema.
* **Neurological symptoms (tingling sensations in hands and decreased sensation to light touch in feet)**: These symptoms can occur in systemic amyloidosis, which can cause peripheral neuropathy and other neurological manifestations.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Normal hemoglobin levels**: AL amyloidosis is often associated with anemia, which is not present in this patient (hemoglobin levels are within normal range).
* **Absence of lymphadenopathy or splenomegaly**: AL amyloidosis can be associated with lymphadenopathy or splenomegaly, which are not mentioned in the physical examination.
* **No mention of macroglossia**: Macroglossia (enlarged tongue) is a characteristic feature of AL amyloidosis, but it is not mentioned in the physical examination.
* **Mild hepatomegaly (only 2 cm below the costal margin)**: While hepatomegaly can occur in AL amyloidosis, the degree of hepatomegaly in this patient is relatively mild, which might suggest a less severe disease process.
* **Well-controlled rheumatoid arthritis**: The patient's rheumatoid arthritis is well-controlled with methotrexate, which might reduce the likelihood of AL amyloidosis, as uncontrolled rheumatoid arthritis is a risk factor for developing AL amyloidosis.

**2. Cardiac Amyloidosis**

* **Normal systolic function on echocardiogram**: Cardiac amyloidosis often leads to impaired systolic function, but the echocardiogram shows normal systolic function.
* **No murmurs on cardiac examination**: Cardiac amyloidosis can cause murmurs due to valvular involvement, but none are mentioned in the physical examination.
* **BP 110/70 mmHg**: Cardiac amyloidosis can cause hypotension due to impaired cardiac function, but the patient's blood pressure is within normal range.
* **No mention of arrhythmias**: Cardiac amyloidosis can cause arrhythmias, but there is no mention of any arrhythmias in the patient's presentation.
* **Pulse 90/min**: While the pulse is slightly elevated, it is not as high as might be expected in cardiac amyloidosis, which can cause significant cardiac dysfunction.

**3. Systemic Amyloidosis with Renal Involvement**

* **Mild proteinuria (only 2+)**: While proteinuria is present, the degree of proteinuria is relatively mild, which might suggest a less severe disease process.
* **Serum creatinine 1.5 mg/dL (only mildly elevated)**: While the serum creatinine is elevated, the degree of elevation is relatively mild, which might suggest a less severe disease process.
* **No mention of nephrotic syndrome**: Systemic amyloidosis with renal involvement can cause nephrotic syndrome, but there is no mention of significant edema, hypoalbuminemia, or hyperlipidemia.
* **No hematuria**: Systemic amyloidosis with renal involvement can cause hematuria, but urinalysis shows only proteinuria without hematuria.
* **Normal blood pressure**: Systemic amyloidosis with renal involvement can cause hypertension, but the patient's blood pressure is within normal range.","Based on the patient's presentation, laboratory results, and physical examination, the final diagnosis is:

**Primary Amyloidosis (AL Amyloidosis) with Cardiac and Renal Involvement**

The diagnosis is supported by the following key findings:

1. **Elevated serum free light chains**: This is a hallmark of AL amyloidosis, indicating the presence of a monoclonal protein that can deposit as amyloid fibrils in tissues.
2. **Amyloid deposits in abdominal fat biopsy**: This is a definitive diagnostic finding for amyloidosis, confirming the presence of amyloid fibrils in tissues.
3. **Proteinuria and elevated serum creatinine**: These findings indicate renal involvement, which is a common feature of AL amyloidosis.
4. **Elevated BNP and concentric left ventricular hypertrophy on echocardiogram**: These findings suggest cardiac involvement, which is also a common feature of AL amyloidosis.
5. **Symptoms of fatigue, weight loss, and shortness of breath**: These symptoms are consistent with AL amyloidosis, which can cause multi-organ dysfunction and failure.

The patient's well-controlled rheumatoid arthritis and lack of other underlying conditions that could cause amyloidosis (such as chronic infections or inflammatory diseases) also support the diagnosis of primary AL amyloidosis.

**Treatment and Management:**

The treatment and management of AL amyloidosis typically involve a combination of the following:

1. **Chemotherapy**: To reduce the production of the monoclonal protein and slow disease progression.
2. **Supportive care**: To manage symptoms and prevent complications, such as cardiac and renal failure.
3. **Stem cell transplantation**: In eligible patients, to replace the abnormal plasma cells with healthy ones.
4. **Dialysis and renal transplantation**: In patients with advanced renal disease, to support renal function and improve quality of life.

The patient's prognosis will depend on the extent of organ involvement, response to treatment, and overall health status. Close monitoring and follow-up with a multidisciplinary team, including a hematologist, cardiologist, nephrologist, and other specialists, will be essential to manage the patient's condition and improve outcomes.","Based on the final diagnosis of Primary Amyloidosis (AL Amyloidosis) with Cardiac and Renal Involvement, the following additional steps should be taken:

**Immediate Steps:**

1. **Cardiology consultation**: To further evaluate the patient's cardiac involvement and determine the best course of management for cardiac amyloidosis.
2. **Nephrology consultation**: To assess the patient's renal function and determine the need for dialysis or other renal supportive measures.
3. **Hematology consultation**: To discuss treatment options for AL amyloidosis, including chemotherapy and stem cell transplantation.
4. **Imaging studies**: To assess the extent of organ involvement, including:
	* Echocardiogram with strain imaging to evaluate cardiac function
	* Cardiac MRI to assess cardiac amyloidosis
	* Abdominal ultrasound to evaluate liver and spleen size
	* CT scan or MRI to evaluate for any other organ involvement (e.g., lung, liver, spleen)
5. **Laboratory tests**: To monitor the patient's condition and response to treatment, including:
	* Serial serum free light chain measurements
	* Urine protein electrophoresis (UPEP) to monitor proteinuria
	* Complete blood counts (CBC) and blood chemistry tests to monitor for anemia, renal function, and other complications

**Short-Term Steps:**

1. **Chemotherapy**: To reduce the production of the monoclonal protein and slow disease progression.
2. **Supportive care**: To manage symptoms and prevent complications, such as:
	* Diuretics to manage edema and fluid overload
	* Beta blockers to manage cardiac symptoms
	* Pain management for neuropathic pain
3. **Stem cell transplantation evaluation**: To determine if the patient is a candidate for stem cell transplantation, which can potentially cure AL amyloidosis.
4. **Dialysis and renal transplantation evaluation**: To determine if the patient requires dialysis or renal transplantation to support renal function.

**Long-Term Steps:**

1. **Regular follow-up**: With a multidisciplinary team, including a hematologist, cardiologist, nephrologist, and other specialists, to monitor the patient's condition and adjust treatment as needed.
2. **Serial imaging studies**: To monitor the extent of organ involvement and response to treatment.
3. **Laboratory tests**: To monitor the patient's condition and response to treatment, including serial serum free light chain measurements and urine protein electrophoresis (UPEP).
4. **Supportive care**: To manage symptoms and prevent complications, such as cardiac and renal failure, and to improve quality of life.

By taking these additional steps, the patient's condition can be managed, and the risk of complications and disease progression can be reduced.","{""Score"":1,""Rationale"":""Only 'Amyloidosis' matches a rubric item; 'Cardiac Amyloidosis' and 'Systemic Amyloidosis with Renal Involvement' do not correspond to 'Congestive Cardiac Failure' or 'Chronic Kidney Disease' as listed.""}","{""Score"":2,""Rationale"":""The answer includes details matching the Amyloidosis component of the rubric, earning 2 points. It does not mention Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma as listed in the rubric, so no points are awarded for those items.""}","{""Score"":0,""Rationale"":""The answer does not match any of the rubric's required concepts (no opposing findings for amyloidosis, no discussion of congestive cardiac failure, chronic kidney disease, or amyloid deposition on biopsy with absence of Bence Jones proteins). Hence zero points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies amyloidosis, cites fatigue, proteinuria, and biopsy confirming amyloid deposits, matching the high‑scoring example.""}","{""Score"":2,""Rationale"":""The answer includes Cardiac MRI, which matches one of the three required items (2 points). It does not mention Bone marrow biopsy or Renal biopsy, so no points for those.""}",7.0
"History of Present Illness
A 59-year-old male presents with swelling and pain in his right leg that started 3 days ago. He was discharged from the hospital 2 weeks ago after undergoing knee replacement surgery, during which he received prophylactic low molecular weight heparin. He reports intermittent fever and recent episodes of palpitations. He denies chest pain, shortness of breath, or prior deep vein thrombosis (DVT). 

  Past Medical History
He has a history of osteoarthritis requiring knee replacement. He has hypertension, controlled with amlodipine, and a history of dyslipidemia. He has no history of malignancy or clotting disorders. 

  Physical Examination
VITALS: BP 125/80 mmHg, pulse 102/min, temperature 99.6°F. 
GEN: Appears mildly uncomfortable. 
CARDIAC: Regular rhythm, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender. 
EXT: Right leg swollen with mild erythema and tenderness along the femoral vein. Homans' sign is positive. No ulcers or skin changes. 
SKIN: Petechiae on both forearms. 

  Laboratory Results
Platelet count has decreased to 58 x 10³/μL from 210 x 10³/μL 10 days ago. D-dimer is elevated at 5.2 μg/mL. The Heparin-PF4 antibody test is positive. Ultrasound reveals a thrombus in the right femoral vein.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Heparin-Induced Thrombocytopenia (HIT)**: The patient has a history of recent heparin use, a significant drop in platelet count, and a positive Heparin-PF4 antibody test, which are all consistent with HIT.
2. **Deep Vein Thrombosis (DVT)**: The patient presents with swelling, pain, and erythema in the right leg, and the ultrasound reveals a thrombus in the right femoral vein, which is consistent with DVT.
3. **Thromboembolic Disease with Immune-Mediated Thrombocytopenia**: The patient's presentation of thrombosis (DVT) and thrombocytopenia, along with the presence of petechiae and a positive Heparin-PF4 antibody test, could also suggest an immune-mediated thrombocytopenia, potentially related to the recent heparin use or an underlying autoimmune process.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* Recent use of low molecular weight heparin (LMWH) for prophylaxis after knee replacement surgery
* Significant drop in platelet count (from 210 x 10³/μL to 58 x 10³/μL) within 10 days of heparin use
* Positive Heparin-PF4 antibody test, which is a specific test for HIT
* Presence of thrombosis (DVT) despite heparin use, which is a paradoxical finding in HIT
* Timing of thrombocytopenia and thrombosis is consistent with HIT, which typically occurs 5-10 days after heparin initiation

**2. Deep Vein Thrombosis (DVT)**

* Recent surgery (knee replacement) and hospitalization, which are risk factors for DVT
* Swelling, pain, and erythema in the right leg, which are classic symptoms of DVT
* Positive Homans' sign, which is a physical examination finding suggestive of DVT
* Ultrasound confirmation of a thrombus in the right femoral vein, which is diagnostic of DVT
* Elevated D-dimer level (5.2 μg/mL), which is a sensitive but non-specific test for DVT

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* Presence of thrombosis (DVT) and thrombocytopenia, which could suggest an underlying immune-mediated process
* Petechiae on both forearms, which could indicate an immune-mediated thrombocytopenia
* Recent surgery and hospitalization, which can trigger an immune response and increase the risk of thromboembolic disease
* Positive Heparin-PF4 antibody test, which could suggest an immune-mediated response to heparin
* However, this diagnosis is less likely than HIT, as the patient's presentation and laboratory findings are more consistent with HIT than a primary immune-mediated thrombocytopenia.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Heparin-Induced Thrombocytopenia (HIT)**

* The patient's platelet count did not drop to a level typically seen in HIT (usually < 20 x 10³/μL) before the diagnosis was made, although the drop from 210 x 10³/μL to 58 x 10³/μL is still significant.
* The patient does not have a history of previous thrombocytopenia or thrombosis, which can be seen in some patients with HIT.
* The patient's vital signs, such as blood pressure (125/80 mmHg) and pulse (102/min), are not indicative of a severe systemic inflammatory response, which can be seen in some cases of HIT.
* Expected findings that are not present include:
	+ More severe thrombocytopenia
	+ Evidence of arterial thrombosis (e.g., stroke, myocardial infarction)
	+ More significant elevation of liver enzymes or other markers of inflammation

**2. Deep Vein Thrombosis (DVT)**

* The patient does not have a history of previous DVT or pulmonary embolism, which can increase the risk of recurrent DVT.
* The patient's symptoms of DVT (swelling, pain, and erythema) are relatively mild, and the patient does not have any signs of phlegmasia cerulea dolens (a severe form of DVT).
* The patient's D-dimer level (5.2 μg/mL) is elevated, but not to the extent typically seen in patients with large or proximal DVT.
* Expected findings that are not present include:
	+ More significant swelling or edema of the affected leg
	+ Increased warmth or tenderness of the affected leg
	+ Signs of pulmonary embolism (e.g., shortness of breath, chest pain)

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* The patient's presentation and laboratory findings are more consistent with HIT than a primary immune-mediated thrombocytopenia.
* The patient does not have a history of autoimmune disorders or other conditions that can increase the risk of immune-mediated thrombocytopenia.
* The patient's petechiae are relatively mild and limited to the forearms, which is not typical of more severe immune-mediated thrombocytopenia.
* Expected findings that are not present include:
	+ More significant thrombocytopenia or anemia
	+ Evidence of other autoimmune disorders (e.g., lupus, rheumatoid arthritis)
	+ Presence of other autoantibodies or immune markers (e.g., ANA, RF)","Based on the patient's presentation, laboratory findings, and risk factors, the final diagnosis is:

**Heparin-Induced Thrombocytopenia (HIT)**

The patient's recent use of low molecular weight heparin (LMWH) for prophylaxis after knee replacement surgery, significant drop in platelet count, positive Heparin-PF4 antibody test, and presence of thrombosis (DVT) despite heparin use are all consistent with HIT. The patient's presentation and laboratory findings are more consistent with HIT than a primary immune-mediated thrombocytopenia or a simple DVT.

The diagnosis of HIT is further supported by the following:

* The patient's platelet count dropped significantly (from 210 x 10³/μL to 58 x 10³/μL) within 10 days of heparin use, which is a typical timeframe for HIT to develop.
* The patient has a positive Heparin-PF4 antibody test, which is a specific test for HIT.
* The patient has thrombosis (DVT) despite heparin use, which is a paradoxical finding in HIT.

The patient's DVT is likely a complication of HIT, and the patient's petechiae may be related to the thrombocytopenia associated with HIT.

**Management:**

* Discontinue all forms of heparin immediately.
* Initiate an alternative anticoagulant, such as a direct thrombin inhibitor (e.g., argatroban) or a factor Xa inhibitor (e.g., fondaparinux).
* Monitor platelet count and adjust anticoagulation therapy as needed.
* Treat the DVT with anticoagulation and consider thrombectomy or other interventions if necessary.

**Prognosis:**

* The patient's prognosis is generally good if HIT is recognized and treated promptly.
* However, the patient is at risk for further thrombotic complications and bleeding due to the thrombocytopenia and anticoagulation therapy.
* Close monitoring and follow-up are necessary to manage the patient's condition and prevent further complications.","Based on the final diagnosis of Heparin-Induced Thrombocytopenia (HIT), the following additional steps should be taken:

1. **Notify the patient's surgical team and other healthcare providers**: Inform the patient's surgical team and other healthcare providers about the diagnosis of HIT, as they may need to adjust the patient's anticoagulation therapy and monitor for signs of thrombosis or bleeding.
2. **Order additional laboratory tests**: Order additional laboratory tests, such as:
	* Complete Blood Count (CBC) with differential to monitor the patient's platelet count and other blood cell lines.
	* Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) to monitor the patient's coagulation status.
	* Fibrinogen level to monitor for signs of disseminated intravascular coagulation (DIC).
3. **Initiate alternative anticoagulation therapy**: Initiate an alternative anticoagulant, such as:
	* Argatroban: a direct thrombin inhibitor that can be used to treat HIT.
	* Fondaparinux: a factor Xa inhibitor that can be used to treat HIT.
	* Danaparoid: a low-molecular-weight heparinoid that can be used to treat HIT.
4. **Monitor for signs of thrombosis or bleeding**: Closely monitor the patient for signs of thrombosis or bleeding, such as:
	* Chest pain or shortness of breath (signs of pulmonary embolism).
	* Leg pain or swelling (signs of DVT).
	* Abdominal pain or bleeding (signs of gastrointestinal bleeding).
5. **Consider consulting a hematologist**: Consider consulting a hematologist to help manage the patient's HIT and anticoagulation therapy.
6. **Develop a plan for long-term anticoagulation**: Develop a plan for long-term anticoagulation therapy, as the patient may require ongoing anticoagulation to prevent further thrombotic complications.
7. **Educate the patient and family**: Educate the patient and family about the diagnosis of HIT, the risks and benefits of alternative anticoagulation therapy, and the importance of monitoring for signs of thrombosis or bleeding.
8. **Document the patient's allergy to heparin**: Document the patient's allergy to heparin in their medical record, to prevent future exposure to heparin and reduce the risk of recurrent HIT.

By taking these additional steps, the patient's healthcare team can help manage their HIT and reduce the risk of further thrombotic complications.","{""Score"":2,""Rationale"":""The answer includes Heparin-Induced Thrombocytopenia (HIT) and Deep Vein Thrombosis (DVT), which match two of the three rubric items. The third item, Fat embolism, is not present, so only 2 of 3 points are awarded.""}","{""Score"":4,""Rationale"":""The answer correctly includes Heparin-Induced Thrombocytopenia and Deep Vein Thrombosis as described in the rubric, earning 2 points each. It does not mention Fat Embolism, instead providing an unrelated diagnosis, so no points for the third item. Total score is 4 out of 6.""}","{""Score"":4,""Rationale"":""The answer correctly identifies Heparin-Induced Thrombocytopenia (HIT) and Deep Vein Thrombosis (DVT), matching two of the three concepts in the high‑scoring example (2 points each). It does not mention Fat Embolism, the third required concept, so no points are awarded for that item. Hence, 4 out of 6 points are earned.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Heparin-Induced Thrombocytopenia (HIT) and includes the key features listed in the high‑scoring example (recent heparin use, thrombocytopenia, positive Heparin‑PF4 antibody, new thrombosis, petechiae), thus meeting all rubric criteria for full credit.""}","{""Score"":4,""Rationale"":""The answer includes starting alternative anticoagulation (argatroban, fondaparinux) and monitoring platelet count via CBC, matching two rubric items (2 points each). It does not explicitly state discontinuing all heparin products, so that item is missing (0 points). Total 4/6.""}",16.0
"History of Present Illness
A 44-year-old female presents with a 6-month history of unintentional weight gain, especially in her abdomen and face. She notes the appearance of purple striae on her abdomen and has recently developed increased acne and facial hair growth. She reports fatigue, insomnia, and mood swings. Over the last month, she has had progressive weakness in her legs, which is most noticeable when climbing stairs.

Past Medical History
The patient has a history of polycystic ovary syndrome (PCOS), for which she has been treated intermittently with oral contraceptives. She denies any history of diabetes or previous steroid use.

Physical Examination
VITALS: BP 170/110 mmHg, pulse 82/min, temperature 98.5°F.
GEN: Overweight, with moon facies and a central distribution of fat.
CARDIAC: Regular rhythm, no murmurs.
PULM: Clear to auscultation bilaterally.
ABD: Obese with prominent abdominal striae and a rounded abdomen.
EXT: Bilateral proximal muscle weakness, especially in the thighs.
SKIN: Purple striae on the abdomen, mild acne on the back and face.

Laboratory Results
Serum cortisol levels are elevated, with a 24-hour urine cortisol excretion of 500 μg/day (normal: <50 μg/day). ACTH is raised, and MRI of the pituitary gland shows a small adenoma.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Cushing's Syndrome**: The patient's symptoms such as weight gain, particularly in the abdominal and facial areas, purple striae on the abdomen, acne, facial hair growth, and proximal muscle weakness are consistent with Cushing's syndrome. The elevated serum cortisol levels and 24-hour urine cortisol excretion also support this diagnosis.
2. **Cushing's Disease**: The presence of a small adenoma on the MRI of the pituitary gland, along with elevated ACTH levels, suggests that the patient may have Cushing's disease, which is a specific type of Cushing's syndrome caused by an ACTH-secreting pituitary adenoma.
3. **Adrenal Cushing's Syndrome (less likely)**: Although less likely given the elevated ACTH levels, adrenal Cushing's syndrome is still a possible diagnosis. This condition is caused by excess cortisol production by the adrenal glands, which could be due to an adrenal tumor or hyperplasia. However, the presence of a pituitary adenoma and elevated ACTH levels make this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Cushing's Syndrome**

Supporting findings:

* **Elevated serum cortisol levels**: The patient's serum cortisol levels are elevated, which is a key diagnostic criterion for Cushing's syndrome.
* **High 24-hour urine cortisol excretion**: The patient's 24-hour urine cortisol excretion is 500 μg/day, which is significantly higher than the normal range (<50 μg/day).
* **Clinical symptoms**: The patient's symptoms, such as weight gain (particularly in the abdominal and facial areas), purple striae on the abdomen, acne, facial hair growth, and proximal muscle weakness, are consistent with Cushing's syndrome.
* **Hypertension**: The patient's blood pressure is elevated (170/110 mmHg), which is a common finding in Cushing's syndrome.

**2. Cushing's Disease**

Supporting findings:

* **Elevated ACTH levels**: The patient's ACTH levels are elevated, which suggests that the excess cortisol production is driven by an ACTH-secreting tumor.
* **Pituitary adenoma on MRI**: The presence of a small adenoma on the MRI of the pituitary gland is consistent with Cushing's disease, which is caused by an ACTH-secreting pituitary adenoma.
* **Clinical symptoms**: The patient's symptoms, such as weight gain, purple striae, acne, facial hair growth, and proximal muscle weakness, are consistent with Cushing's disease.
* **Absence of previous steroid use**: The patient denies any history of previous steroid use, which makes it more likely that the Cushing's syndrome is due to an endogenous cause, such as a pituitary adenoma.

**3. Adrenal Cushing's Syndrome (less likely)**

Supporting findings:

* **Elevated serum cortisol levels**: The patient's serum cortisol levels are elevated, which could be consistent with adrenal Cushing's syndrome.
* **Clinical symptoms**: The patient's symptoms, such as weight gain, purple striae, acne, facial hair growth, and proximal muscle weakness, could be consistent with adrenal Cushing's syndrome.

However, the following findings make adrenal Cushing's syndrome less likely:

* **Elevated ACTH levels**: The patient's ACTH levels are elevated, which suggests that the excess cortisol production is driven by an ACTH-secreting tumor, rather than an adrenal tumor.
* **Pituitary adenoma on MRI**: The presence of a small adenoma on the MRI of the pituitary gland is more consistent with Cushing's disease than adrenal Cushing's syndrome.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Cushing's Syndrome**

Opposing findings:

* **Absence of other classic symptoms**: While the patient has some classic symptoms of Cushing's syndrome, such as weight gain and purple striae, she does not have other common symptoms, such as buffalo hump, easy bruising, or poor wound healing.
* **Normal temperature**: The patient's temperature is normal (98.5°F), whereas some patients with Cushing's syndrome may have an elevated temperature due to the immunosuppressive effects of excess cortisol.
* **No mention of osteoporosis or fractures**: Cushing's syndrome can cause osteoporosis and increase the risk of fractures, but there is no mention of this in the patient's history.

Expected findings that are not present:

* **Hyperglycemia**: Cushing's syndrome can cause hyperglycemia due to the glucocorticoid effects of excess cortisol, but there is no mention of elevated blood glucose levels in the patient's history.
* **Hypokalemia**: Cushing's syndrome can cause hypokalemia due to the mineralocorticoid effects of excess cortisol, but there is no mention of low potassium levels in the patient's history.

**2. Cushing's Disease**

Opposing findings:

* **Relatively mild symptoms**: The patient's symptoms are relatively mild compared to what is often seen in Cushing's disease, which can cause more severe and rapid onset of symptoms.
* **No visual field defects**: The patient does not have any visual field defects, which can occur in Cushing's disease due to the compression of the optic chiasm by a large pituitary adenoma.
* **No mention of headaches or cranial nerve deficits**: Cushing's disease can cause headaches and cranial nerve deficits due to the compression of surrounding structures by the pituitary adenoma, but there is no mention of these symptoms in the patient's history.

Expected findings that are not present:

* **Elevated prolactin levels**: Some patients with Cushing's disease may have elevated prolactin levels due to the compression of the pituitary stalk or the production of prolactin by the adenoma, but there is no mention of this in the patient's history.
* **Growth hormone deficiency**: Cushing's disease can cause growth hormone deficiency due to the compression of the normal pituitary tissue by the adenoma, but there is no mention of this in the patient's history.

**3. Adrenal Cushing's Syndrome (less likely)**

Opposing findings:

* **Elevated ACTH levels**: The patient's ACTH levels are elevated, which suggests that the excess cortisol production is driven by an ACTH-secreting tumor, rather than an adrenal tumor.
* **Pituitary adenoma on MRI**: The presence of a small adenoma on the MRI of the pituitary gland is more consistent with Cushing's disease than adrenal Cushing's syndrome.
* **No mention of adrenal mass on imaging**: There is no mention of an adrenal mass on imaging, which would be expected in adrenal Cushing's syndrome.

Expected findings that are not present:

* **Low ACTH levels**: Adrenal Cushing's syndrome is typically associated with low ACTH levels due to the negative feedback of excess cortisol on the pituitary gland, but the patient's ACTH levels are elevated.
* **High aldosterone levels**: Adrenal Cushing's syndrome can cause high aldosterone levels due to the production of aldosterone by the adrenal tumor, but there is no mention of this in the patient's history.","Based on the patient's symptoms, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Cushing's Disease**

The diagnosis of Cushing's disease is supported by the following findings:

* Elevated serum cortisol levels and 24-hour urine cortisol excretion, which indicate excess cortisol production.
* Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor.
* The presence of a small adenoma on the MRI of the pituitary gland, which is consistent with an ACTH-secreting pituitary adenoma.
* The patient's symptoms, such as weight gain, purple striae, acne, facial hair growth, and proximal muscle weakness, are consistent with Cushing's disease.
* The absence of any other obvious cause of Cushing's syndrome, such as exogenous steroid use or an adrenal tumor.

The diagnosis of Cushing's disease is further supported by the fact that the patient's symptoms and laboratory results are consistent with the expected findings in Cushing's disease, and the presence of a pituitary adenoma on MRI provides a clear explanation for the excess ACTH production.

The patient's history of polycystic ovary syndrome (PCOS) is also notable, as PCOS is a common comorbidity in patients with Cushing's disease. However, the patient's symptoms and laboratory results are more consistent with Cushing's disease than with PCOS alone.

Overall, the combination of clinical, laboratory, and imaging findings supports the diagnosis of Cushing's disease, and further evaluation and treatment should be directed towards managing the underlying pituitary adenoma and excess cortisol production.","Based on the diagnosis of Cushing's disease, the following additional steps should be taken:

1. **Confirmatory testing**: Perform a high-dose dexamethasone suppression test to confirm the diagnosis of Cushing's disease. This test can help differentiate between Cushing's disease and other forms of Cushing's syndrome.
2. **Pituitary MRI with contrast**: Perform a pituitary MRI with contrast to better characterize the size and location of the pituitary adenoma.
3. **Visual field testing**: Perform visual field testing to assess for any visual field defects that may be caused by the pituitary adenoma.
4. **Endocrine evaluation**: Perform a comprehensive endocrine evaluation to assess for any other hormonal imbalances that may be caused by the pituitary adenoma, such as hypogonadism, hypothyroidism, or growth hormone deficiency.
5. **Surgical evaluation**: Refer the patient to a neurosurgeon for evaluation and consideration of transsphenoidal surgery to remove the pituitary adenoma.
6. **Medical management**: Initiate medical management with a glucocorticoid receptor antagonist, such as mifepristone, to control the symptoms of Cushing's disease while awaiting surgery.
7. **Monitoring**: Closely monitor the patient's blood pressure, blood glucose, and electrolyte levels, as well as their overall clinical status, to ensure that they are stable and that the medical management is effective.
8. **Consideration of other treatments**: Consider other treatments, such as radiation therapy or medical therapy with a somatostatin analogue, if the patient is not a candidate for surgery or if the surgery is not successful.

Long-term management:

1. **Post-operative care**: Provide post-operative care and monitoring to ensure that the patient is recovering well from surgery and that their hormonal imbalances are being managed.
2. **Hormone replacement therapy**: Consider hormone replacement therapy to replace any deficient hormones, such as cortisol, thyroid hormone, or growth hormone.
3. **Regular follow-up**: Schedule regular follow-up appointments to monitor the patient's clinical status, hormonal levels, and overall health.
4. **Screening for other conditions**: Screen the patient for other conditions that may be associated with Cushing's disease, such as osteoporosis, diabetes, or hypertension.

By taking these additional steps, the patient can receive comprehensive care and management for their Cushing's disease, and their symptoms and hormonal imbalances can be effectively managed.","{""Score"":2,""Rationale"":""Student listed Cushing's Syndrome and Cushing's Disease, matching two of the three rubric concepts; PCOS was not included, so only 2 points awarded.""}","{
  ""Score"": 4,
  ""Rationale"": ""The answer correctly includes the key findings for Cushing's Disease and Cushing's Syndrome as listed in the rubric, earning 2 points each. However, it does not mention Polycystic Ovary Syndrome (PCOS) or its distinguishing features, resulting in 0 points for that category.""
}","{""Score"":0,""Rationale"":""The answer does not mention any of the specific concepts listed in the high‑scoring example (e.g., no opposing findings for Cushing's Disease, no raised ACTH or pituitary microadenoma for Cushing’s Syndrome/Exogenous Steroids, and no discussion of PCOS). Therefore, no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Cushing's Disease and includes the key features from the rubric (weight gain, purple striae, elevated cortisol, ACTH findings, pituitary adenoma), matching the high‑scoring example.""}","{""Score"":2,""Rationale"":""The answer includes a dexamethasone suppression test, matching one rubric item (2 points). It does not mention ACTH measurement or referral to endocrinology, so no points for those.""}",10.0
"History Of Present Illness 
A 76-year-old male presents to his primary care physician with complaints of back and thigh pain lasting for 2 weeks. He reports no pain while sitting or lying down, but walking induces severe pain in his lower back, buttocks, and calves. He also feels fatigued and slightly febrile. A referring cardiologist noted recent test results, since the onset of pain, showing a new anemia and azotemia. Notably, a few days prior to the onset of his symptoms, the patient underwent coronary angioplasty, during which he received heparin for 48 hours.
Past Medical History 
Ischemic heart disease had first been diagnosed ten years earlier, at which time a coronary artery bypass procedure was done. 
Physical Examination 
VITALS: 99.6° F.; pulse was 94/min and regular; BP was 110/88 mmHg. 
GEN: Well appearing 
CARDS: There is a grade III/VI apical systolic murmur. 
PULM: Lungs are clear to auscultation bilaterally, no wheezing, or consolidations noted. 
ABD: Soft, non-tender to palpation 
MSK: He does not have tenderness of his spine or pelvis. Spinal mobility is normal, as is the mobility of his hips. Standing is painless; however, pain is experienced in his low back, buttocks and calves within a minute of feeble running in place. The pain disappears shortly after exercise is discontinued. 
EXT: Peripheral pulses were symmetrically reduced, but palpable. The neurological examination was normal. 
SKIN: Patient has a purple, red, lacy rash over his low back and buttocks. 
Laboratory 
WBC of 11.5 x 103 cells /μL; differential of 64% segs, 20% lymphocytes, 3% monocytes, 12% eosinophils and 1% basophil. The hematocrit was 28% and the platelet count was 315 x 103 /μL. The erythrocyte sedimentation rate was 99 mm/h. Urinalysis was normal except for 2+ proteinuria. Serum creatinine was 4.0 mg/dL; sodium was 145 mEq/L; potassium 4.0 mEq/L; chloride 105 mEq/L. SGOT was 27 U/L; GGT was 90 U/L; alkaline phosphatase was 153 U/L.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Aortoiliac Occlusive Disease**: The patient's symptoms of back and thigh pain that worsen with walking (claudication) and improve with rest, along with the presence of a purple, red, lacy rash over his low back and buttocks, suggest a possible diagnosis of aortoiliac occlusive disease. The reduced peripheral pulses and elevated erythrocyte sedimentation rate (ESR) also support this diagnosis.
2. **Cholesterol Crystal Embolization**: The patient's recent history of coronary angioplasty and heparin use, along with the development of azotemia, anemia, and eosinophilia, suggest a possible diagnosis of cholesterol crystal embolization. This condition occurs when cholesterol crystals break off from the walls of the aorta and embolize to smaller arteries, causing inflammation and damage.
3. **Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**: The patient's symptoms of back and thigh pain, along with the presence of a purple, red, lacy rash, elevated ESR, and anemia, suggest a possible diagnosis of vasculitis. The patient's age and the presence of a systolic murmur also increase the likelihood of giant cell arteritis, although the lack of headache or jaw claudication makes this diagnosis less likely. Polyarteritis nodosa is another possibility, although the patient's symptoms and laboratory results do not fully align with this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Aortoiliac Occlusive Disease**

* Supportive findings:
	+ Claudication symptoms: The patient experiences severe pain in his lower back, buttocks, and calves when walking, which improves with rest.
	+ Reduced peripheral pulses: The patient has symmetrically reduced peripheral pulses, which suggests impaired blood flow to the lower extremities.
	+ Age: The patient is 76 years old, which is a common age range for the development of aortoiliac occlusive disease.
	+ History of ischemic heart disease: The patient has a history of ischemic heart disease, which increases the risk of developing peripheral arterial disease, including aortoiliac occlusive disease.
* Risk factors:
	+ Smoking: Although not mentioned, smoking is a significant risk factor for aortoiliac occlusive disease, and it is possible that the patient has a history of smoking.
	+ Hypertension: The patient's blood pressure is 110/88 mmHg, which is relatively well-controlled, but it is possible that the patient has a history of uncontrolled hypertension, which increases the risk of developing aortoiliac occlusive disease.
	+ Hyperlipidemia: The patient's lipid profile is not provided, but hyperlipidemia is a common risk factor for aortoiliac occlusive disease.

**2. Cholesterol Crystal Embolization**

* Supportive findings:
	+ Recent coronary angioplasty: The patient underwent coronary angioplasty a few days prior to the onset of symptoms, which increases the risk of cholesterol crystal embolization.
	+ Heparin use: The patient received heparin for 48 hours after the procedure, which can increase the risk of cholesterol crystal embolization.
	+ Azotemia: The patient has elevated serum creatinine (4.0 mg/dL), which suggests kidney damage, a common complication of cholesterol crystal embolization.
	+ Eosinophilia: The patient has an elevated eosinophil count (12%), which is a common finding in cholesterol crystal embolization.
* Risk factors:
	+ Age: The patient is 76 years old, which increases the risk of cholesterol crystal embolization.
	+ History of atherosclerotic disease: The patient has a history of ischemic heart disease, which increases the risk of developing atherosclerotic disease, including cholesterol crystal embolization.

**3. Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**

* Supportive findings:
	+ Elevated ESR: The patient has an elevated erythrocyte sedimentation rate (99 mm/h), which suggests inflammation.
	+ Anemia: The patient has a low hematocrit (28%), which can be seen in vasculitis.
	+ Purple, red, lacy rash: The patient has a rash over his low back and buttocks, which could be a manifestation of vasculitis.
	+ Systemic symptoms: The patient has fatigue and a low-grade fever, which are common systemic symptoms of vasculitis.
* Risk factors:
	+ Age: The patient is 76 years old, which increases the risk of developing giant cell arteritis.
	+ Sex: Although not mentioned, giant cell arteritis is more common in women, but it can occur in men, especially at an older age.
	+ Polymyalgia rheumatica: Although not mentioned, polymyalgia rheumatica is a common comorbidity with giant cell arteritis, and it is possible that the patient has this condition.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Aortoiliac Occlusive Disease**

* Opposing findings:
	+ Normal spinal mobility: The patient has normal spinal mobility, which suggests that the pain is not related to spinal stenosis or other spinal conditions.
	+ No tenderness of the spine or pelvis: The patient does not have tenderness of the spine or pelvis, which suggests that the pain is not related to a musculoskeletal condition.
	+ Presence of a purple, red, lacy rash: The patient has a rash over his low back and buttocks, which is not a typical finding in aortoiliac occlusive disease.
* Expected findings that are not present:
	+ Intermittent claudication at a consistent distance: The patient experiences pain in his low back, buttocks, and calves when walking, but it is not clear if this occurs at a consistent distance.
	+ Buttock or thigh atrophy: The patient does not have any mention of buttock or thigh atrophy, which can be seen in advanced aortoiliac occlusive disease.

**2. Cholesterol Crystal Embolization**

* Opposing findings:
	+ Normal urinalysis: The patient has a normal urinalysis, except for 2+ proteinuria, which suggests that the kidney damage is not severe.
	+ Absence of livedo reticularis: The patient does not have livedo reticularis, which is a common finding in cholesterol crystal embolization.
	+ Presence of a systolic murmur: The patient has a grade III/VI apical systolic murmur, which is not typically associated with cholesterol crystal embolization.
* Expected findings that are not present:
	+ Hypertension: The patient's blood pressure is 110/88 mmHg, which is relatively well-controlled, whereas hypertension is often seen in patients with cholesterol crystal embolization.
	+ Abdominal pain: The patient does not have abdominal pain, which can be seen in cholesterol crystal embolization due to embolization to the mesenteric arteries.

**3. Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**

* Opposing findings:
	+ Absence of headache or jaw claudication: The patient does not have headache or jaw claudication, which are common symptoms of giant cell arteritis.
	+ Normal lung examination: The patient has a normal lung examination, which suggests that the vasculitis is not affecting the lungs.
	+ Presence of a systolic murmur: The patient has a grade III/VI apical systolic murmur, which is not typically associated with vasculitis.
* Expected findings that are not present:
	+ Fever > 100.4°F: The patient has a low-grade fever (99.6°F), but it is not as high as expected in vasculitis.
	+ Weight loss: The patient does not have weight loss, which is a common symptom of vasculitis.
	+ Neurological symptoms: The patient does not have neurological symptoms, such as numbness, tingling, or weakness, which can be seen in vasculitis.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Cholesterol Crystal Embolization**

The patient's recent history of coronary angioplasty and heparin use, along with the development of azotemia, anemia, and eosinophilia, are all consistent with cholesterol crystal embolization. The patient's symptoms of back and thigh pain, which worsen with walking, are also consistent with this diagnosis. The presence of a purple, red, lacy rash over the patient's low back and buttocks, known as livedo reticularis, is a classic finding in cholesterol crystal embolization.

The patient's laboratory results, including the elevated erythrocyte sedimentation rate (ESR), anemia, and eosinophilia, also support this diagnosis. The patient's kidney function is impaired, as evidenced by the elevated serum creatinine, which is a common complication of cholesterol crystal embolization.

While the patient's symptoms and laboratory results could also be consistent with aortoiliac occlusive disease or vasculitis, the recent history of coronary angioplasty and heparin use, along with the presence of livedo reticularis, make cholesterol crystal embolization the most likely diagnosis.

**Treatment:**

The treatment for cholesterol crystal embolization is primarily supportive, as there is no specific therapy to dissolve the cholesterol crystals. The patient should be managed with:

* Pain control: The patient's pain should be managed with analgesics, such as acetaminophen or opioids.
* Blood pressure control: The patient's blood pressure should be controlled to reduce the risk of further embolization.
* Renal protection: The patient's kidney function should be monitored closely, and measures should be taken to protect the kidneys from further damage.
* Antiplatelet therapy: The patient should be started on antiplatelet therapy, such as aspirin, to reduce the risk of further thrombosis.

**Prognosis:**

The prognosis for cholesterol crystal embolization is variable, depending on the severity of the embolization and the patient's underlying medical conditions. Some patients may experience a full recovery, while others may have persistent symptoms and complications, such as kidney damage or peripheral artery disease.","Based on the final diagnosis of Cholesterol Crystal Embolization, the following additional steps should be taken:

1. **Imaging studies:**
	* Order a renal ultrasound to assess for any signs of kidney damage or infarction.
	* Consider a CT angiogram or MRI angiogram to evaluate the extent of the embolization and to rule out other potential causes of the patient's symptoms.
2. **Laboratory tests:**
	* Order a complete blood count (CBC) with differential to monitor for any changes in the patient's blood cell counts.
	* Check the patient's electrolyte panel, including potassium, sodium, and chloride, to monitor for any signs of kidney dysfunction.
	* Order a urinalysis to monitor for any signs of kidney damage or infection.
3. **Medications:**
	* Start the patient on antiplatelet therapy, such as aspirin, to reduce the risk of further thrombosis.
	* Consider starting the patient on a statin to reduce the risk of further cholesterol crystal embolization.
	* Continue to manage the patient's pain with analgesics, such as acetaminophen or opioids.
4. **Consultations:**
	* Consult with a nephrologist to manage the patient's kidney function and to monitor for any signs of kidney damage.
	* Consult with a cardiologist to manage the patient's cardiovascular risk factors and to monitor for any signs of cardiac complications.
5. **Monitoring:**
	* Monitor the patient's vital signs, including blood pressure, heart rate, and oxygen saturation, closely.
	* Monitor the patient's kidney function, including serum creatinine and urine output, closely.
	* Monitor the patient's pain levels and adjust the patient's pain management plan as needed.
6. **Follow-up:**
	* Schedule follow-up appointments with the patient's primary care physician, nephrologist, and cardiologist to monitor the patient's condition and to adjust the treatment plan as needed.
	* Consider scheduling a follow-up imaging study, such as a CT angiogram or MRI angiogram, to evaluate the extent of the embolization and to monitor for any signs of further complications.

By taking these additional steps, the patient's condition can be closely monitored, and the risk of further complications can be reduced.","{""Score"":1,""Rationale"":""Only 'Cholesterol Crystal Embolization' matches the rubric's 'Cholesterol embolism'; the other two diagnoses are not listed in the rubric.""}","{""Score"":2,""Rationale"":""The answer includes features of cholesterol embolism (recent PCI, renal failure, eosinophilia) matching the rubric, earning 2 points. It does not list acute interstitial nephritis or peripheral arterial disease as named diagnoses, so no points for those categories.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the specific concepts or expected/ opposing findings listed for Cholesterol embolism, Acute interstitial nephritis, or Peripheral arterial disease in the rubric; it discusses different diagnoses, so no points are awarded.""}","{""Score"":2,""Rationale"":""Student correctly identified the diagnosis as cholesterol embolism (cholesterol crystal embolization), matching the high‑scoring example.""}","{""Score"":2,""Rationale"":""The answer includes a nephrology consultation, which matches a concept in the high‑scoring example (item 2). It does not mention arterial ultrasounds of the lower extremities/ABI or a renal biopsy, so no points for items 1 and 3.""}",7.0
"History of Present Illness
A 42-year-old male presents with chronic burning pain in his hands and feet, which has worsened over the past year. He has frequent episodes of abdominal cramping and diarrhea. He reports fatigue, decreased exercise tolerance, and intermittent difficulty with vision. He recalls a history of a similar condition in his older brother, who died from kidney failure at the age of 48. 

Past Medical History
The patient has been diagnosed with chronic kidney disease of unknown etiology. He also has a history of hearing loss and occasional headaches. There is a history of diabetes and hypertension. 

Physical Examination
VITALS: BP 150/90 mmHg, pulse 82/min, temperature 98.6°F. 
GEN: Thin, mildly fatigued. 
HEENT: Corneal opacities visible on slit lamp examination. 
CARDIAC: No murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, hepatosplenomegaly noted. 
EXT: Angiokeratomas on the lower abdomen and upper thighs. 
SKIN: No significant rashes. 

Laboratory Results
Serum creatinine is elevated at 2.8 mg/dL. Urinalysis shows 3+ proteinuria with no red blood cells. Alpha-galactosidase A activity in plasma is significantly reduced.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Fabry Disease**: This is a genetic disorder caused by a deficiency of alpha-galactosidase A, which is consistent with the significantly reduced enzyme activity in the patient's plasma. The patient's symptoms, such as chronic burning pain in hands and feet, abdominal cramping, diarrhea, and corneal opacities, are also consistent with Fabry disease.
2. **Diabetic Neuropathy**: The patient's history of diabetes and symptoms of chronic burning pain in hands and feet, as well as decreased exercise tolerance, could suggest diabetic neuropathy. However, the presence of other symptoms such as corneal opacities and angiokeratomas are not typical of diabetic neuropathy.
3. **Amyloidosis**: The patient's symptoms, such as chronic kidney disease, hepatosplenomegaly, and neuropathic pain, could be consistent with amyloidosis. However, the significantly reduced alpha-galactosidase A activity in plasma and the presence of angiokeratomas are more specific for Fabry disease.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Fabry Disease**

* **Reduced alpha-galactosidase A activity in plasma**: This is a specific and sensitive test for Fabry disease, and the significantly reduced enzyme activity in the patient's plasma is a strong indicator of this diagnosis.
* **Family history**: The patient's older brother died from kidney failure at a young age, which could be consistent with Fabry disease, as it is a genetic disorder that can lead to kidney failure.
* **Chronic burning pain in hands and feet**: This is a classic symptom of Fabry disease, which is caused by the accumulation of globotriaosylceramide (Gb3) in peripheral nerves.
* **Corneal opacities**: The presence of corneal opacities on slit lamp examination is a common finding in Fabry disease.
* **Angiokeratomas**: The presence of angiokeratomas on the lower abdomen and upper thighs is a characteristic skin lesion of Fabry disease.
* **Chronic kidney disease**: Fabry disease can lead to kidney failure, and the patient's elevated serum creatinine and proteinuria are consistent with this diagnosis.

**2. Diabetic Neuropathy**

* **History of diabetes**: The patient has a history of diabetes, which is a major risk factor for diabetic neuropathy.
* **Chronic burning pain in hands and feet**: This is a common symptom of diabetic neuropathy, which is caused by damage to peripheral nerves.
* **Decreased exercise tolerance**: This could be related to the patient's diabetes and neuropathy, as well as other factors such as kidney disease.
* **Hypertension**: The patient's hypertension could be contributing to his kidney disease and neuropathy.
* **However, the presence of corneal opacities, angiokeratomas, and significantly reduced alpha-galactosidase A activity in plasma are not typical of diabetic neuropathy**, which makes this diagnosis less likely.

**3. Amyloidosis**

* **Chronic kidney disease**: Amyloidosis can lead to kidney failure, and the patient's elevated serum creatinine and proteinuria are consistent with this diagnosis.
* **Hepatosplenomegaly**: The presence of hepatosplenomegaly could be related to amyloid deposition in these organs.
* **Neuropathic pain**: Amyloidosis can cause neuropathic pain, although the specific pattern of pain in this patient is more consistent with Fabry disease.
* **Family history**: Some forms of amyloidosis are hereditary, which could be relevant given the patient's family history of kidney disease.
* **However, the presence of significantly reduced alpha-galactosidase A activity in plasma and angiokeratomas are not typical of amyloidosis**, which makes this diagnosis less likely.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Fabry Disease**

* **Absence of cardiac involvement**: Fabry disease often involves the heart, with findings such as left ventricular hypertrophy, valvular disease, or arrhythmias. However, the patient's cardiac examination is normal, with no murmurs or gallops.
* **No significant rash**: While angiokeratomas are present, they are limited to the lower abdomen and upper thighs. Some patients with Fabry disease may have more widespread skin involvement, including rash or lesions on the face, arms, or legs.
* **No reported heat intolerance**: Some patients with Fabry disease may experience heat intolerance or sweating abnormalities, but this is not mentioned in the patient's history.
* **Normal pulse**: Fabry disease can cause autonomic dysfunction, leading to abnormalities in heart rate or blood pressure regulation. However, the patient's pulse is normal, with no evidence of orthostatic hypotension or other autonomic dysfunction.

**2. Diabetic Neuropathy**

* **Presence of corneal opacities**: Diabetic neuropathy does not typically cause corneal opacities, which are a characteristic finding in Fabry disease.
* **Angiokeratomas**: The presence of angiokeratomas is not typical of diabetic neuropathy, and is more consistent with Fabry disease.
* **Significantly reduced alpha-galactosidase A activity in plasma**: This finding is not consistent with diabetic neuropathy, and is a specific indicator of Fabry disease.
* **Absence of typical diabetic neuropathy patterns**: Diabetic neuropathy often presents with a specific pattern of nerve involvement, such as distal symmetric polyneuropathy. However, the patient's symptoms of chronic burning pain in hands and feet, abdominal cramping, and diarrhea do not fit a typical diabetic neuropathy pattern.
* **No mention of typical diabetic complications**: The patient's history does not mention other typical complications of diabetes, such as retinopathy or foot ulcers.

**3. Amyloidosis**

* **Absence of macroglossia**: Amyloidosis can cause enlargement of the tongue (macroglossia), but this is not mentioned in the patient's history.
* **No reported weight loss**: Amyloidosis can cause weight loss, but the patient's weight is not mentioned, and there is no report of significant weight loss.
* **Normal cardiac examination**: Amyloidosis can cause cardiac involvement, including left ventricular hypertrophy, valvular disease, or arrhythmias. However, the patient's cardiac examination is normal.
* **Significantly reduced alpha-galactosidase A activity in plasma**: This finding is not consistent with amyloidosis, and is a specific indicator of Fabry disease.
* **Presence of angiokeratomas**: The presence of angiokeratomas is not typical of amyloidosis, and is more consistent with Fabry disease.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Fabry Disease**

The diagnosis of Fabry disease is supported by the following key findings:

1. **Significantly reduced alpha-galactosidase A activity in plasma**: This is a specific and sensitive test for Fabry disease.
2. **Chronic burning pain in hands and feet**: This is a classic symptom of Fabry disease, caused by the accumulation of globotriaosylceramide (Gb3) in peripheral nerves.
3. **Corneal opacities**: The presence of corneal opacities on slit lamp examination is a common finding in Fabry disease.
4. **Angiokeratomas**: The presence of angiokeratomas on the lower abdomen and upper thighs is a characteristic skin lesion of Fabry disease.
5. **Chronic kidney disease**: Fabry disease can lead to kidney failure, and the patient's elevated serum creatinine and proteinuria are consistent with this diagnosis.
6. **Family history**: The patient's older brother died from kidney failure at a young age, which could be consistent with Fabry disease, as it is a genetic disorder that can lead to kidney failure.

The patient's symptoms and laboratory results are consistent with the classic presentation of Fabry disease, and the diagnosis is further supported by the presence of specific findings such as corneal opacities and angiokeratomas. Treatment with enzyme replacement therapy (ERT) or chaperone therapy may be considered to manage the patient's symptoms and slow disease progression.","Based on the diagnosis of Fabry disease, the following additional steps can be taken:

1. **Genetic testing**: Confirm the diagnosis of Fabry disease by performing genetic testing to identify the specific mutation in the GLA gene. This can help to confirm the diagnosis and provide information for family members who may be at risk.
2. **Family screening**: Screen family members for Fabry disease, particularly males, as they are more likely to be affected. This can help to identify other individuals who may be at risk and provide them with appropriate treatment and management.
3. **Cardiac evaluation**: Perform a cardiac evaluation, including an electrocardiogram (ECG) and echocardiogram, to assess for cardiac involvement. Fabry disease can cause cardiac dysfunction, including left ventricular hypertrophy, valvular disease, and arrhythmias.
4. **Neurological evaluation**: Perform a neurological evaluation to assess for neurological involvement, including neuropathic pain, numbness, and weakness.
5. **Renal evaluation**: Perform a renal evaluation, including a renal ultrasound and measurement of glomerular filtration rate (GFR), to assess for renal involvement.
6. **Ophthalmological evaluation**: Perform an ophthalmological evaluation to assess for corneal opacities and other ocular manifestations of Fabry disease.
7. **Pain management**: Develop a pain management plan to manage the patient's chronic pain, which may include medications such as gabapentin, pregabalin, or opioids.
8. **Enzyme replacement therapy (ERT)**: Consider initiating ERT, which can help to replace the deficient alpha-galactosidase A enzyme and reduce the accumulation of globotriaosylceramide (Gb3) in the body.
9. **Chaperone therapy**: Consider initiating chaperone therapy, which can help to stabilize the alpha-galactosidase A enzyme and improve its function.
10. **Regular follow-up**: Schedule regular follow-up appointments to monitor the patient's condition, adjust treatment as needed, and provide ongoing support and management.

Additionally, the following tests can be considered to monitor the patient's condition and response to treatment:

* **Alpha-galactosidase A activity**: Measure the patient's alpha-galactosidase A activity regularly to monitor the effectiveness of ERT or chaperone therapy.
* **Gb3 levels**: Measure the patient's Gb3 levels regularly to monitor the accumulation of Gb3 in the body.
* **Renal function tests**: Monitor the patient's renal function regularly, including serum creatinine, GFR, and urine protein levels.
* **Cardiac function tests**: Monitor the patient's cardiac function regularly, including ECG, echocardiogram, and cardiac MRI.
* **Neurological function tests**: Monitor the patient's neurological function regularly, including nerve conduction studies and electromyography (EMG).","{""Score"":1.5,""Rationale"":""The answer includes Fabry Disease, which matches a high‑scoring item (1 mark). It also lists Diabetic Neuropathy, which corresponds to the Diabetes‑related complication sub‑item worth 0.5 mark. The other diagnoses (Amyloidosis) are not in the rubric, and the required items Chronic Kidney Disease secondary to Alport Syndrome and Polyarteritis Nodosa are missing. Hence total awarded points are 1 + 0.5 = 1.5 out of 3.""}","{""Score"":4,""Rationale"":""The answer includes Fabry Disease and a diabetic complication, matching two concepts from the high‑scoring example (2 points each). It does not mention CKD secondary to Alport Syndrome or Polyarteritis Nodosa, so no points are awarded for those. Total = 4 points.""}","{""Score"":0,""Rationale"":""Student answer does not provide the specific opposing findings for the diagnoses listed in the rubric (Fabry Disease, CKD secondary to Alport, Diabetes related complications, Polyarteritis Nodosa); therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Fabry Disease and lists the key clinical features from the rubric (burning pain, angiokeratomas, corneal opacities, family history, reduced alpha-galactosidase A activity), thus matching the high‑scoring example.""}","{""Score"":6,""Rationale"":""The answer includes genetic testing, enzyme replacement therapy, and monitoring of renal function, matching all three rubric items.""}",13.5
"History of Present Illness
A 55-year-old female presents with a 3-month history of progressive difficulty swallowing, drooping of her eyelids, and muscle weakness. She reports that her symptoms are worse by the end of the day and improve with rest. She has also noticed difficulty speaking and has frequent choking episodes when drinking liquids. There is no associated pain, and she denies any other systemic symptoms.

  Past Medical History
She has no significant medical history but was diagnosed with hypothyroidism 5 years ago and has been on levothyroxine since then. Family history is unremarkable.

  Physical Examination
VITALS: BP 130/80 mmHg, pulse 75/min, temperature 98.7°F. 
GEN: Well-appearing, no distress. 
HEENT: Ptosis noted in both eyelids, worse on the right side. 
PULM: Clear to auscultation bilaterally. 
NEURO: Proximal muscle weakness
EXT: No edema

  Laboratory Results
Acetylcholine receptor antibodies are positive. Serum creatine kinase (CK) is normal.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Myasthenia Gravis (MG)**: The patient's symptoms of progressive difficulty swallowing, drooping of eyelids (ptosis), muscle weakness, and worsening of symptoms by the end of the day are consistent with MG. The presence of acetylcholine receptor antibodies also supports this diagnosis.
2. **Amyotrophic Lateral Sclerosis (ALS)**: Although less likely, ALS could be considered due to the patient's symptoms of progressive muscle weakness, difficulty swallowing, and speech difficulties. However, the presence of acetylcholine receptor antibodies and the lack of other typical ALS symptoms (e.g., fasciculations, upper motor neuron signs) make this diagnosis less likely.
3. **Lambert-Eaton Myasthenic Syndrome (LEMS)**: This rare autoimmune disorder can present with similar symptoms to MG, including muscle weakness, ptosis, and difficulty swallowing. However, LEMS often has a distinct pattern of weakness, with symptoms improving with repeated use or exercise, which is not clearly described in this patient's case. Additionally, LEMS is often associated with small cell lung cancer, which is not mentioned in the patient's history.","Here are the findings/risk factors supporting each possible diagnosis:

**1. Myasthenia Gravis (MG)**

* **Positive acetylcholine receptor antibodies**: This is a specific and sensitive test for MG, and the presence of these antibodies strongly supports this diagnosis.
* **Fluctuating symptoms**: The patient's symptoms worsen by the end of the day and improve with rest, which is a classic pattern seen in MG.
* **Ptosis and diplopia**: The patient's drooping eyelids (ptosis) and difficulty speaking are common symptoms of MG.
* **Proximal muscle weakness**: The patient's physical examination reveals proximal muscle weakness, which is a typical finding in MG.
* **Absence of other systemic symptoms**: MG is often an isolated condition, and the lack of other systemic symptoms (e.g., fever, weight loss) makes this diagnosis more likely.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Progressive muscle weakness**: The patient's symptoms of progressive muscle weakness could be consistent with ALS.
* **Difficulty swallowing and speaking**: These symptoms are also common in ALS.
* **Absence of sensory symptoms**: ALS is a pure motor neuron disease, and the lack of sensory symptoms (e.g., numbness, tingling) in this patient is consistent with this diagnosis.
* **Age of onset**: The patient's age (55 years) is within the typical age range for ALS.

However, there are also some findings that argue against ALS:

* **Normal serum creatine kinase (CK) levels**: Elevated CK levels are common in ALS, and the normal level in this patient makes ALS less likely.
* **Absence of upper motor neuron signs**: ALS typically presents with a combination of upper and lower motor neuron signs, and the lack of upper motor neuron signs (e.g., hyperreflexia, spasticity) in this patient makes ALS less likely.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Proximal muscle weakness**: The patient's physical examination reveals proximal muscle weakness, which is a common finding in LEMS.
* **Difficulty swallowing and speaking**: These symptoms are also seen in LEMS.
* **Ptosis**: The patient's drooping eyelids (ptosis) could be consistent with LEMS.

However, there are also some findings that argue against LEMS:

* **Absence of characteristic pattern of weakness**: LEMS often presents with a distinct pattern of weakness, with symptoms improving with repeated use or exercise, which is not clearly described in this patient's case.
* **Normal serum CK levels**: Elevated CK levels are common in LEMS, and the normal level in this patient makes LEMS less likely.
* **Lack of association with small cell lung cancer**: LEMS is often associated with small cell lung cancer, and the lack of this association in the patient's history makes LEMS less likely.","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Myasthenia Gravis (MG)**

* **Normal serum creatine kinase (CK) levels**: While normal CK levels do not rule out MG, elevated CK levels are sometimes seen in patients with MG, particularly those with significant muscle weakness.
* **Lack of clear exacerbation with heat or stress**: MG symptoms often worsen with heat, stress, or infection, but this is not clearly described in the patient's case.
* **No mention of respiratory muscle involvement**: MG can affect respiratory muscles, leading to respiratory failure, but there is no mention of this in the patient's history or physical examination.
* **No improvement with edrophonium test**: While not mentioned, a positive edrophonium test (also known as a Tensilon test) can provide rapid and temporary improvement in symptoms, which would support the diagnosis of MG.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Normal serum creatine kinase (CK) levels**: Elevated CK levels are common in ALS, particularly in the early stages of the disease.
* **Lack of upper motor neuron signs**: ALS typically presents with a combination of upper and lower motor neuron signs, including hyperreflexia, spasticity, and fasciculations. The absence of these signs in the patient's physical examination makes ALS less likely.
* **No mention of fasciculations**: Fasciculations are a common finding in ALS, particularly in the tongue and limbs.
* **No clear progression of symptoms**: ALS is characterized by a progressive and relentless course, but the patient's symptoms have been relatively stable over the past 3 months.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Lack of characteristic pattern of weakness**: LEMS often presents with a distinct pattern of weakness, with symptoms improving with repeated use or exercise. This pattern is not clearly described in the patient's case.
* **Normal serum creatine kinase (CK) levels**: Elevated CK levels are common in LEMS, particularly in patients with significant muscle weakness.
* **No mention of autonomic dysfunction**: LEMS can be associated with autonomic dysfunction, including dry mouth, impotence, and orthostatic hypotension, but these symptoms are not mentioned in the patient's history.
* **No association with small cell lung cancer**: LEMS is often associated with small cell lung cancer, and the lack of this association in the patient's history makes LEMS less likely.

These findings opposing each possible diagnosis highlight the importance of considering multiple factors and evaluating the patient's symptoms and test results in the context of their overall clinical presentation.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Myasthenia Gravis (MG)**

The diagnosis of MG is supported by the following key findings:

1. **Positive acetylcholine receptor antibodies**: This is a specific and sensitive test for MG, and the presence of these antibodies strongly supports this diagnosis.
2. **Fluctuating symptoms**: The patient's symptoms worsen by the end of the day and improve with rest, which is a classic pattern seen in MG.
3. **Ptosis and diplopia**: The patient's drooping eyelids (ptosis) and difficulty speaking are common symptoms of MG.
4. **Proximal muscle weakness**: The patient's physical examination reveals proximal muscle weakness, which is a typical finding in MG.

While the patient's symptoms could also be consistent with other conditions, such as ALS or LEMS, the presence of positive acetylcholine receptor antibodies and the characteristic pattern of fluctuating symptoms make MG the most likely diagnosis.

**Treatment and Management:**

The patient will likely be started on **pyridostigmine**, an acetylcholinesterase inhibitor, to improve muscle strength and reduce symptoms. Additionally, the patient may be considered for **immunosuppressive therapy**, such as prednisone, to reduce the production of acetylcholine receptor antibodies.

**Further Evaluation:**

To confirm the diagnosis and rule out other conditions, the patient may undergo further evaluation, including:

1. **Electromyography (EMG)**: to assess muscle function and detect any abnormal electrical activity.
2. **Repetitive nerve stimulation (RNS)**: to evaluate the response of muscles to repeated nerve stimulation.
3. **Computed tomography (CT) or magnetic resonance imaging (MRI)**: to rule out any underlying conditions, such as thymoma, that may be associated with MG.

**Prognosis:**

The prognosis for patients with MG is generally good, with most patients experiencing significant improvement in symptoms with treatment. However, the disease can be unpredictable, and some patients may experience exacerbations or remissions over time.","Based on the diagnosis of Myasthenia Gravis (MG), the following additional steps can be taken:

**Immediate Steps:**

1. **Initiate treatment with pyridostigmine**: Start the patient on pyridostigmine, an acetylcholinesterase inhibitor, to improve muscle strength and reduce symptoms.
2. **Monitor for side effects**: Closely monitor the patient for side effects of pyridostigmine, such as nausea, vomiting, and diarrhea.
3. **Assess respiratory function**: Evaluate the patient's respiratory function, including lung function tests and arterial blood gases, to determine if respiratory support is needed.

**Short-Term Steps:**

1. **Schedule follow-up appointments**: Schedule follow-up appointments with the patient to monitor their response to treatment and adjust the dose of pyridostigmine as needed.
2. **Order laboratory tests**: Order laboratory tests, such as complete blood count (CBC), electrolyte panel, and liver function tests, to monitor for potential side effects of treatment.
3. **Consider immunosuppressive therapy**: Consider starting the patient on immunosuppressive therapy, such as prednisone, to reduce the production of acetylcholine receptor antibodies.

**Long-Term Steps:**

1. **Thymectomy evaluation**: Evaluate the patient for thymectomy, a surgical procedure to remove the thymus gland, which can help improve symptoms in some patients with MG.
2. **Plasmapheresis or intravenous immunoglobulin (IVIG)**: Consider plasmapheresis or IVIG therapy for patients who do not respond to immunosuppressive therapy or who experience severe exacerbations.
3. **Lifestyle modifications**: Educate the patient on lifestyle modifications, such as avoiding heat, stress, and fatigue, to help manage symptoms and improve quality of life.

**Specialized Care:**

1. **Neurology consultation**: Consult with a neurologist to confirm the diagnosis and develop a treatment plan.
2. **Pulmonology consultation**: Consult with a pulmonologist to evaluate and manage respiratory function.
3. **Physical therapy**: Refer the patient to a physical therapist to develop a exercise program to maintain muscle strength and mobility.

**Patient Education:**

1. **Disease education**: Educate the patient on the diagnosis, treatment options, and prognosis of MG.
2. **Medication management**: Educate the patient on how to manage their medications, including dosing, side effects, and potential interactions.
3. **Symptom management**: Educate the patient on how to manage their symptoms, including avoiding triggers and using energy-conserving techniques.","{""Score"":2,""Rationale"":""The answer includes Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome, which match two of the three required items. It does not include Hypothyroid Myopathy and adds ALS, which is not in the rubric, so only 2 points are awarded.""}","{""Score"":4,""Rationale"":""The answer includes relevant concepts for Myasthenia Gravis (positive antibodies, fluctuating symptoms, ptosis) and Lambert‑Eaton Myasthenic Syndrome (proximal weakness, ptosis, dysphagia) matching items in the rubric, earning 2 points each. It does not mention hypothyroid myopathy at all, and it omits the EMG findings required for full credit on MG and LEMS, so no points are awarded for that condition. Total score is 4 out of 6.""}","{""Score"":0,""Rationale"":""The response does not contain the specific opposing findings outlined in the rubric for Myasthenia Gravis, Lambert‑Eaton Myasthenic Syndrome, or Hypothyroid Myopathy, and omits the hypothyroid myopathy category entirely.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Myasthenia Gravis and includes the key concepts from the rubric: ptosis, fluctuating fatigue improving with rest, positive acetylcholine receptor antibodies, and references to EMG testing, matching the high‑scoring example.""}","{""Score"":0,""Rationale"":""The answer does not mention any of the three required items (CT/MRI of chest, Edrophonium test, or thyroid function assessment) listed in the rubric, so no points are awarded.""}",8.0
"History of Present Illness
A 41-year-old male presents with a 4-week history of chronic sinus congestion, bloody nasal discharge, and persistent cough with hemoptysis. He also complains of joint pain and swelling in both knees and ankles. He reports unintentional weight loss of 8 kg over the last 2 months. He denies any recent trauma, travel, or exposure to sick contacts.

  Past Medical History
The patient has no significant medical history but was previously healthy. He has no known drug allergies and does not smoke or drink alcohol.

  Physical Examination
VITALS: BP 120/78 mmHg, pulse 88/min, temperature 99.2°F. 
GEN: Well-appearing but fatigued. 
HEENT: Nasal mucosal ulcerations, bloody discharge from both nostrils. 
PULM: Bilateral rales in the lungs. 
ABD: Soft, non-tender. 
EXT: Swelling in both knees and ankles, with mild erythema. 
SKIN: No rashes.

  Laboratory Results
WBC count is 12.8 x 103/μL, with a mild left shift. ESR is elevated at 75 mm/h. Serum creatinine is 1.5 mg/dL, and urinalysis shows 1+ proteinuria with RBC casts. c-ANCA is positive. Chest CT shows multiple nodular lung infiltrates and cavities.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**: This is a type of vasculitis that affects small- and medium-sized blood vessels, and is characterized by the presence of c-ANCA. The patient's symptoms, such as sinus congestion, bloody nasal discharge, hemoptysis, and kidney involvement (elevated serum creatinine and proteinuria with RBC casts), are consistent with GPA.
2. **Microscopic Polyangiitis (MPA)**: This is another type of vasculitis that affects small blood vessels, and can present with similar symptoms to GPA, including sinusitis, lung involvement, and kidney disease. However, MPA is typically associated with p-ANCA rather than c-ANCA.
3. **Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**: This is a type of vasculitis that is characterized by the presence of asthma, eosinophilia, and vasculitis affecting multiple organs. While the patient does not have a history of asthma, the presence of sinusitis, lung involvement, and joint pain could be consistent with this diagnosis. However, the lack of eosinophilia in the laboratory results makes this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **c-ANCA positivity**: The patient's positive c-ANCA result is a strong indicator of GPA, as this antibody is found in approximately 80-90% of patients with active GPA.
* **Upper and lower respiratory tract involvement**: The patient's symptoms of chronic sinus congestion, bloody nasal discharge, and hemoptysis are consistent with the typical presentation of GPA, which often involves the upper and lower respiratory tracts.
* **Renal involvement**: The patient's elevated serum creatinine, proteinuria, and RBC casts are indicative of kidney disease, which is a common feature of GPA.
* **Systemic symptoms**: The patient's unintentional weight loss, joint pain, and swelling are consistent with the systemic nature of GPA.

**2. Microscopic Polyangiitis (MPA)**

* **Renal involvement**: The patient's elevated serum creatinine, proteinuria, and RBC casts are consistent with the renal disease that is often seen in MPA.
* **Pulmonary involvement**: The patient's symptoms of cough, hemoptysis, and bilateral lung infiltrates are consistent with the pulmonary disease that can occur in MPA.
* **Systemic symptoms**: The patient's unintentional weight loss, joint pain, and swelling are consistent with the systemic nature of MPA.
* **Note**: However, the patient's c-ANCA positivity is not typical of MPA, which is usually associated with p-ANCA. This makes MPA a less likely diagnosis.

**3. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**

* **Asthma-like symptoms**: Although not explicitly mentioned, the patient's chronic sinus congestion and cough could be indicative of asthma-like symptoms, which are often seen in Churg-Strauss Syndrome.
* **Pulmonary involvement**: The patient's symptoms of cough, hemoptysis, and bilateral lung infiltrates are consistent with the pulmonary disease that can occur in Churg-Strauss Syndrome.
* **Systemic symptoms**: The patient's unintentional weight loss, joint pain, and swelling are consistent with the systemic nature of Churg-Strauss Syndrome.
* **Note**: However, the lack of eosinophilia in the laboratory results and the absence of a clear history of asthma make this diagnosis less likely. Additionally, the patient's c-ANCA positivity is not typical of Churg-Strauss Syndrome, which is usually associated with p-ANCA or ANCA negativity.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **Lack of granulomatous inflammation on physical examination**: Although the patient has nasal mucosal ulcerations, there is no mention of granulomatous inflammation, which is a hallmark of GPA.
* **No mention of subglottic stenosis**: Subglottic stenosis is a common feature of GPA, particularly in patients with long-standing disease. The absence of this finding does not rule out GPA, but it is a notable omission.
* **Mild anemia not mentioned**: Patients with GPA often have mild anemia, which is not mentioned in the laboratory results.
* **Normal blood pressure**: Despite the presence of renal disease, the patient's blood pressure is normal, which is not typical of GPA patients with significant renal involvement.

**2. Microscopic Polyangiitis (MPA)**

* **c-ANCA positivity**: As mentioned earlier, MPA is typically associated with p-ANCA, not c-ANCA. The presence of c-ANCA in this patient makes MPA a less likely diagnosis.
* **Lack of leukocytoclastic vasculitis**: MPA is often characterized by leukocytoclastic vasculitis, which is not mentioned in the patient's skin examination.
* **No mention of gastrointestinal symptoms**: Gastrointestinal symptoms, such as abdominal pain and diarrhea, are common in MPA, but are not mentioned in the patient's history.
* **Normal platelet count**: Thrombocytopenia is a common feature of MPA, but the patient's platelet count is not mentioned as being abnormal.

**3. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)**

* **Lack of eosinophilia**: The most notable finding opposing this diagnosis is the lack of eosinophilia in the laboratory results. Eosinophilia is a hallmark of Churg-Strauss Syndrome, and its absence makes this diagnosis less likely.
* **No history of asthma**: Although the patient has chronic sinus congestion, there is no clear history of asthma, which is a common feature of Churg-Strauss Syndrome.
* **No mention of neuropathy**: Mononeuritis multiplex is a common feature of Churg-Strauss Syndrome, but there is no mention of neuropathy in the patient's history.
* **c-ANCA positivity**: As mentioned earlier, Churg-Strauss Syndrome is typically associated with p-ANCA or ANCA negativity, not c-ANCA. The presence of c-ANCA in this patient makes Churg-Strauss Syndrome a less likely diagnosis.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

The following findings support this diagnosis:

* c-ANCA positivity, which is a sensitive and specific marker for GPA
* Upper and lower respiratory tract involvement, including chronic sinus congestion, bloody nasal discharge, and hemoptysis
* Renal involvement, including elevated serum creatinine, proteinuria, and RBC casts
* Systemic symptoms, including unintentional weight loss, joint pain, and swelling
* Bilateral lung infiltrates and cavities on chest CT, which are consistent with the pulmonary disease seen in GPA

While the patient's presentation is consistent with GPA, it is essential to note that the diagnosis of GPA is based on a combination of clinical, laboratory, and radiological findings, as well as the exclusion of other potential causes of the patient's symptoms.

The patient's symptoms and laboratory results are not entirely consistent with Microscopic Polyangiitis (MPA) or Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome), making GPA the most likely diagnosis.

**Treatment:**

The treatment of GPA typically involves a combination of immunosuppressive medications, including:

* Cyclophosphamide or rituximab to induce remission
* Glucocorticoids to reduce inflammation and prevent relapse
* Azathioprine or methotrexate to maintain remission
* Trimethoprim-sulfamethoxazole to prevent Pneumocystis jirovecii pneumonia

The patient's treatment plan should be individualized based on the severity of their disease, their overall health, and their response to therapy. Regular monitoring of the patient's symptoms, laboratory results, and radiological findings is essential to adjust the treatment plan as needed and to prevent complications.","Based on the final diagnosis of Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA), the following additional steps should be taken:

**Immediate Steps:**

1. **Initiate immunosuppressive therapy**: Start the patient on cyclophosphamide or rituximab to induce remission, along with glucocorticoids to reduce inflammation and prevent relapse.
2. **Supportive care**: Provide supportive care, including oxygen therapy, bronchodilators, and pain management, as needed.
3. **Monitor renal function**: Closely monitor the patient's renal function, including serum creatinine, urine output, and electrolyte levels.

**Short-Term Steps (within 1-2 weeks):**

1. **Repeat laboratory tests**: Repeat laboratory tests, including complete blood count, electrolyte panel, and liver function tests, to monitor the patient's response to treatment.
2. **Imaging studies**: Repeat imaging studies, including chest CT and sinus CT, to assess the patient's response to treatment and to monitor for potential complications.
3. **Consultations**: Consult with a rheumatologist, nephrologist, and pulmonologist to ensure a comprehensive approach to the patient's care.

**Long-Term Steps (within 2-6 months):**

1. **Maintenance therapy**: Transition the patient to maintenance therapy, including azathioprine or methotrexate, to maintain remission.
2. **Regular follow-up**: Schedule regular follow-up appointments with the patient to monitor their disease activity, adjust their treatment plan as needed, and prevent complications.
3. **Patient education**: Educate the patient on the importance of adherence to their treatment plan, potential side effects of medications, and signs and symptoms of disease flare-ups.

**Additional Considerations:**

1. **Infectious disease screening**: Screen the patient for infectious diseases, including tuberculosis and hepatitis B, to prevent potential complications.
2. **Vaccinations**: Ensure the patient is up-to-date on all recommended vaccinations, including pneumococcal and influenza vaccines.
3. **Psychological support**: Provide psychological support to the patient, including counseling and support groups, to help them cope with the emotional and social impact of their disease.","{""Score"":1,""Rationale"":""The answer includes Granulomatosis with Polyangiitis (Wegener's), which matches one rubric item. The other two diagnoses (Microscopic Polyangiitis and Eosinophilic Granulomatosis with Polyangiitis) are not listed in the rubric, so no points for them.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Granulomatosis with Polyangiitis and provides matching findings (c-ANCA positivity, sinus congestion, hemoptysis, renal involvement, joint symptoms) as listed in the rubric, earning 2 points. It does not mention Rheumatoid Arthritis or Infectious Causes, so no points are awarded for those sections. Total score is 2 out of 6.""}","{""Score"":0,""Rationale"":""Student's answer does not match any of the concepts or diagnoses listed in the rubric (GPA, RA, Infectious Causes) and provides opposing findings rather than the supporting points required; therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Granulomatosis with Polyangiitis (GPA) and lists the key supporting findings (c-ANCA positivity, sinus involvement, hemoptysis, joint involvement, lung abnormalities) that match the high‑scoring example, thus meeting all rubric criteria for full credit.""}","{""Score"":2,""Rationale"":""The answer includes referral to a rheumatologist and initiation of immunosuppressive therapy (cyclophosphamide/rituximab), matching rubric item 2 (2 points). It does not mention serial urine analysis for proteinuria nor joint imaging, so no points for items 1 and 3.""}",7.0
"History of Present Illness
A 32-year-old female presents with a 3-day history of severe abdominal pain, nausea, vomiting, and constipation. The pain is intermittent, severe, and located in the lower abdomen, associated with dark urine and pale stools. She has also noted difficulty with muscle weakness, especially in her legs. The pain started after she began taking oral contraceptives for the past 2 weeks. She has had similar episodes in the past, but they were less intense and occurred about once a year.

  Past Medical History
She has a history of irregular menstrual cycles and has been using oral contraceptives for 2 months to regulate them. There is no significant family history of bleeding or liver disorders. She has been generally healthy, with no history of liver disease or significant medications prior to the oral contraceptive use.

  Physical Examination
VITALS: BP 120/75 mmHg, pulse 85/min, temperature 98.9°F. 
GEN: Appears in moderate distress, pale. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Diffuse tenderness to palpation in the lower abdomen with no rebound tenderness. EXT: Muscle weakness in the lower extremities, especially when standing. 
SKIN: No rashes, but urine is dark brown in color.

  Laboratory Results
Urine porphyrin levels are markedly elevated. Serum sodium is low at 130 mEq/L, and liver function tests are normal. Hemoglobin is 11.3 g/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Intermittent Porphyria (AIP)**: The patient's symptoms of severe abdominal pain, nausea, vomiting, constipation, and muscle weakness, along with the elevated urine porphyrin levels, are consistent with AIP. The use of oral contraceptives may have triggered an acute attack.
2. **Porphyria Cutanea Tarda (PCT)**: Although PCT typically presents with skin manifestations, the patient's elevated urine porphyrin levels and abdominal symptoms could suggest a diagnosis of PCT. However, the absence of skin lesions and the presence of acute abdominal symptoms make AIP a more likely diagnosis.
3. **Variegate Porphyria (VP)**: VP is another type of acute porphyria that can present with abdominal pain, nausea, vomiting, and neurological symptoms such as muscle weakness. The patient's symptoms and elevated urine porphyrin levels could be consistent with VP, although the absence of skin lesions and the specific pattern of porphyrin elevation would need to be further evaluated to confirm this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Intermittent Porphyria (AIP)**

* **Elevated urine porphyrin levels**: The patient's urine porphyrin levels are markedly elevated, which is a hallmark of AIP.
* **Severe abdominal pain**: AIP is characterized by severe, intermittent abdominal pain, which is consistent with the patient's symptoms.
* **Neurological symptoms**: The patient's muscle weakness, especially in the lower extremities, is consistent with the neurological symptoms seen in AIP.
* **Triggering factor**: The patient started taking oral contraceptives 2 weeks prior to the onset of symptoms, which is a known triggering factor for AIP attacks.
* **Recurrent episodes**: The patient has a history of similar episodes in the past, although they were less intense, which suggests a recurrent condition like AIP.

**2. Porphyria Cutanea Tarda (PCT)**

* **Elevated urine porphyrin levels**: While PCT is characterized by elevated urine porphyrin levels, the patient's symptoms are not typical of PCT, which usually presents with skin manifestations such as blistering, fragility, and hypertrichosis.
* **Hormonal influence**: The patient's use of oral contraceptives could potentially trigger an episode of PCT, as hormonal changes can exacerbate the condition.
* **However, lack of skin symptoms**: The patient does not have any skin symptoms, which makes PCT a less likely diagnosis.

**3. Variegate Porphyria (VP)**

* **Elevated urine porphyrin levels**: The patient's elevated urine porphyrin levels could be consistent with VP, which is characterized by elevated levels of both urine and fecal porphyrins.
* **Abdominal pain and neurological symptoms**: The patient's symptoms of severe abdominal pain and muscle weakness are consistent with VP, which can present with both gastrointestinal and neurological symptoms.
* **Triggering factor**: The patient's use of oral contraceptives could potentially trigger an episode of VP, as certain medications and hormonal changes can exacerbate the condition.
* **However, lack of skin symptoms**: The patient does not have any skin symptoms, which can sometimes be present in VP, although they are not always a prominent feature of the condition.

It's worth noting that AIP is the most likely diagnosis based on the patient's symptoms and laboratory results, but further testing and evaluation would be necessary to confirm the diagnosis.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Intermittent Porphyria (AIP)**

* **Normal liver function tests**: AIP can sometimes present with abnormal liver function tests, but in this case, the liver function tests are normal.
* **Lack of mental status changes**: AIP can cause mental status changes such as anxiety, depression, and even psychosis, but the patient does not exhibit any of these symptoms.
* **No history of neuropathic pain**: AIP can cause neuropathic pain, such as burning or tingling sensations, but the patient's pain is described as severe and intermittent, without any neuropathic characteristics.
* **Normal hemoglobin level is relatively high**: While the patient's hemoglobin level is slightly low at 11.3 g/dL, it is not as low as would be expected in a patient with AIP, who may experience more significant hemolytic anemia.

**2. Porphyria Cutanea Tarda (PCT)**

* **Lack of skin symptoms**: PCT is characterized by skin symptoms such as blistering, fragility, and hypertrichosis, but the patient does not exhibit any of these symptoms.
* **Acute onset of symptoms**: PCT typically has a more gradual onset of symptoms, whereas the patient's symptoms started suddenly after taking oral contraceptives.
* **No history of liver disease**: PCT is often associated with liver disease, but the patient has no history of liver disease and her liver function tests are normal.
* **Elevated urine porphyrin levels are not specific to PCT**: While the patient's elevated urine porphyrin levels could be consistent with PCT, they are not specific to this condition and can be seen in other types of porphyria as well.

**3. Variegate Porphyria (VP)**

* **Lack of skin symptoms**: VP can sometimes present with skin symptoms such as blistering and fragility, but the patient does not exhibit any of these symptoms.
* **No history of photosensitivity**: VP can cause photosensitivity, but the patient does not report any increased sensitivity to sunlight.
* **Normal liver function tests**: VP can sometimes present with abnormal liver function tests, but in this case, the liver function tests are normal.
* **Elevated urine porphyrin levels are not specific to VP**: While the patient's elevated urine porphyrin levels could be consistent with VP, they are not specific to this condition and can be seen in other types of porphyria as well.

It's worth noting that the absence of certain findings or symptoms does not necessarily rule out a diagnosis, and further testing and evaluation may be necessary to confirm or exclude each of these possible diagnoses.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Acute Intermittent Porphyria (AIP)**

The diagnosis of AIP is supported by the following findings:

* Elevated urine porphyrin levels, which are a hallmark of AIP
* Severe, intermittent abdominal pain, which is a characteristic symptom of AIP
* Neurological symptoms, such as muscle weakness, which are common in AIP
* Triggering factor, such as the use of oral contraceptives, which can precipitate an AIP attack
* Recurrent episodes of similar symptoms in the past, which suggests a chronic condition like AIP

The patient's normal liver function tests, lack of skin symptoms, and relatively high hemoglobin level do not rule out the diagnosis of AIP, as these findings can be variable in patients with this condition.

The diagnosis of AIP is further supported by the exclusion of other possible diagnoses, such as Porphyria Cutanea Tarda (PCT) and Variegate Porphyria (VP), which are less likely given the patient's symptoms and laboratory results.

**Treatment and Management:**

The patient should be managed with:

* Immediate discontinuation of oral contraceptives
* Intravenous glucose and hydration to help manage symptoms
* Pain management with opioids or other analgesics
* Monitoring of urine porphyrin levels and other laboratory tests to assess disease activity
* Consideration of hematin therapy to help reduce symptoms and prevent further attacks
* Genetic counseling and testing to identify any underlying genetic mutations that may be contributing to the patient's condition

**Follow-up:**

The patient should be followed up closely to monitor her symptoms and adjust her treatment plan as needed. She should also be educated on how to manage her condition, including avoiding triggering factors and recognizing the signs and symptoms of an AIP attack.","Based on the diagnosis of Acute Intermittent Porphyria (AIP), the following additional steps should be taken:

1. **Genetic testing**: To confirm the diagnosis and identify the specific genetic mutation responsible for the patient's condition. This can help identify other family members who may be at risk of developing AIP.
2. **Family screening**: To screen first-degree relatives (parents, siblings, and children) for AIP, as they may be at risk of developing the condition.
3. **Porphyrin level monitoring**: To regularly monitor the patient's urine porphyrin levels to assess disease activity and adjust treatment as needed.
4. **Hematin therapy**: To consider hematin therapy to help reduce symptoms and prevent further attacks. Hematin is a medication that can help reduce the production of porphyrins in the liver.
5. **Pain management**: To develop a pain management plan to help the patient manage her abdominal pain and other symptoms. This may include the use of opioids, other analgesics, and alternative therapies such as acupuncture or massage.
6. **Nutritional counseling**: To provide the patient with nutritional counseling to help her manage her condition. This may include avoiding certain foods that can trigger attacks, such as those high in carbohydrates or sugar.
7. **Stress management**: To provide the patient with stress management techniques, such as meditation or yoga, to help her manage stress and reduce the risk of attacks.
8. **Avoidance of triggering factors**: To educate the patient on how to avoid triggering factors, such as certain medications, hormonal changes, and stress, that can precipitate an AIP attack.
9. **Emergency planning**: To develop an emergency plan with the patient, including a plan for managing attacks, seeking medical attention, and communicating with healthcare providers.
10. **Referral to a specialist**: To refer the patient to a specialist, such as a gastroenterologist or a geneticist, who has experience in managing AIP and other porphyrias.

**Additional laboratory tests**:

1. **Complete blood count (CBC)**: To monitor the patient's blood cell counts and detect any signs of anemia or other blood disorders.
2. **Electrolyte panel**: To monitor the patient's electrolyte levels, including sodium, potassium, and chloride.
3. **Liver function tests**: To monitor the patient's liver function and detect any signs of liver damage.
4. **Urine and fecal porphyrin levels**: To regularly monitor the patient's urine and fecal porphyrin levels to assess disease activity.
5. **Genetic testing for other porphyrias**: To rule out other types of porphyrias, such as Porphyria Cutanea Tarda (PCT) or Variegate Porphyria (VP).

**Additional imaging studies**:

1. **Abdominal ultrasound**: To rule out any underlying abdominal pathology, such as gallstones or liver disease.
2. **Magnetic resonance imaging (MRI)**: To evaluate the patient's abdominal and pelvic organs and detect any signs of disease.

By taking these additional steps, the patient can receive comprehensive care and management for her AIP, and reduce the risk of complications and attacks.","{""Score"":0.5,""Rationale"":""The answer includes Acute Intermittent Porphyria, which matches one of the three required diagnoses in the rubric. The other two diagnoses (Porphyria Cutanea Tarda and Variegate Porphyria) do not match the rubric items (Cholecystitis/Gallstones and IBS), so only partial credit is awarded.""}","{""Score"":1,""Rationale"":""The answer includes the correct diagnosis of Acute Intermittent Porphyria with supporting details, matching the rubric. However, it does not mention the other two rubric diagnoses (Cholecystitis/Gallstones and Irritable Bowel Syndrome), so only one of the three possible points is awarded.""}","{""Score"":0,""Rationale"":""Student answer does not match any of the concepts or specific opposing findings listed in the rubric; diagnoses and arguments differ from the high-scoring example.""}","{""Score"": 11.6, ""Rationale"": ""The answer correctly identifies Acute Intermittent Porphyria and includes abdominal pain, muscle weakness, and elevated urine porphyrins, matching four of the five key concepts in the rubric. It omits the dark urine finding, so partial credit is awarded.""}","{""Score"":2,""Rationale"":""The answer includes genetic testing and hematin therapy, matching two rubric items, but does not mention discontinuing oral contraceptives, so only 2 of 3 points are awarded.""}",15.1
"History of Present Illness
A 62-year-old woman visits the emergency department with acute onset of chest pain and shortness of breath that started 2 hours ago after a heated argument with her son. She describes the pain as crushing and radiating to her left arm. She has had intermittent episodes of chest tightness in the past year, typically during stressful situations, but never as severe as this. She denies nausea, vomiting, or syncope.

  Past Medical History
She has a 10-year history of hypertension and osteoarthritis but has no known history of coronary artery disease. She is on lisinopril and acetaminophen. She has no family history of cardiac conditions or sudden death. She denies smoking or alcohol use.

  Physical Examination
VITALS: BP 145/90 mmHg, pulse 100/min, temperature 98.4°F. 
GEN: Mildly anxious, diaphoretic. 
CARDIAC: Tachycardic, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, no hepatosplenomegaly. 
EXT: No cyanosis or edema. 
SKIN: Warm and dry.

  Laboratory Results
Troponin I is elevated at 3.5 ng/mL. Serum brain natriuretic peptide (BNP) is 280 pg/mL. Electrocardiogram (ECG) shows ST-segment elevation in leads V2-V4. ",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and elevated troponin I level are consistent with an acute MI. The ST-segment elevation in leads V2-V4 on the ECG also supports this diagnosis.
2. **Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**: The patient's symptoms started after a heated argument, which could be a stress trigger. The presence of chest pain, shortness of breath, and elevated troponin I level, along with the absence of a clear history of coronary artery disease, could suggest Takotsubo cardiomyopathy.
3. **Acute Coronary Syndrome (ACS) with possible Unstable Angina or Non-ST-Elevation MI**: Although the ECG shows ST-segment elevation, the patient's symptoms and laboratory results could also be consistent with unstable angina or a non-ST-elevation MI, particularly given her history of hypertension and intermittent episodes of chest tightness during stressful situations.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

Supporting findings and risk factors:

* **Elevated troponin I level (3.5 ng/mL)**: This is a specific marker for cardiac damage and is highly suggestive of an MI.
* **ST-segment elevation in leads V2-V4 on the ECG**: This is a classic ECG finding in patients with an ST-elevation MI (STEMI).
* **Crushing chest pain radiating to the left arm**: This is a typical symptom of an MI, particularly if it is severe and persistent.
* **History of hypertension**: Hypertension is a significant risk factor for the development of coronary artery disease, which can lead to an MI.
* **Age (62 years)**: The patient's age is also a risk factor for coronary artery disease and MI.

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

Supporting findings and risk factors:

* **Stressful trigger (heated argument)**: The patient's symptoms started after a stressful event, which is a common trigger for Takotsubo cardiomyopathy.
* **Absence of a clear history of coronary artery disease**: The patient does not have a known history of coronary artery disease, which makes Takotsubo cardiomyopathy a more likely diagnosis.
* **Elevated troponin I level (3.5 ng/mL)**: While this can be seen in MI, it can also be elevated in Takotsubo cardiomyopathy due to cardiac stress and injury.
* **Mildly anxious and diaphoretic**: The patient's physical examination findings suggest that she is experiencing significant stress and anxiety, which is consistent with Takotsubo cardiomyopathy.
* **Female sex**: Takotsubo cardiomyopathy is more common in postmenopausal women, which is consistent with the patient's demographic.

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina or Non-ST-Elevation MI**

Supporting findings and risk factors:

* **History of hypertension**: Hypertension is a significant risk factor for the development of coronary artery disease, which can lead to ACS.
* **Intermittent episodes of chest tightness during stressful situations**: This suggests that the patient may have underlying coronary artery disease that is being exacerbated by stress.
* **Elevated troponin I level (3.5 ng/mL)**: While this can be seen in MI, it can also be elevated in unstable angina or non-ST-elevation MI.
* **Age (62 years)**: The patient's age is also a risk factor for coronary artery disease and ACS.
* **Absence of nausea, vomiting, or syncope**: The patient's symptoms are more consistent with ACS than with other conditions such as pulmonary embolism or cardiac tamponade.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

Opposing findings:

* **Absence of Q waves on the ECG**: While the ECG shows ST-segment elevation, Q waves are often seen in patients with an MI, particularly if it is a transmural infarct.
* **No mention of previous coronary artery disease or risk factors such as diabetes, hyperlipidemia, or smoking**: The patient's lack of traditional risk factors for coronary artery disease makes an MI less likely.
* **Symptoms started after a stressful event**: While MIs can occur at any time, the fact that the patient's symptoms started after a heated argument suggests that stress may be playing a role, which is more consistent with Takotsubo cardiomyopathy.
* **No mention of ECG changes in other leads**: The ECG shows ST-segment elevation in leads V2-V4, but it would be expected to see changes in other leads as well if the patient had a large MI.

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

Opposing findings:

* **Elevated troponin I level (3.5 ng/mL)**: While troponin can be elevated in Takotsubo cardiomyopathy, the level is typically lower than what is seen in an MI. The patient's troponin level is relatively high, which suggests that there may be more significant cardiac damage.
* **ST-segment elevation in leads V2-V4 on the ECG**: While ST-segment elevation can be seen in Takotsubo cardiomyopathy, it is typically more diffuse and not limited to a specific coronary territory.
* **No mention of classic ""apical ballooning"" on echocardiogram**: Takotsubo cardiomyopathy is often characterized by apical ballooning on echocardiogram, which is not mentioned in the patient's case.
* **Patient's age (62 years)**: While Takotsubo cardiomyopathy can occur at any age, it is more common in younger women.

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina or Non-ST-Elevation MI**

Opposing findings:

* **ST-segment elevation in leads V2-V4 on the ECG**: This finding is more consistent with an ST-elevation MI than with unstable angina or non-ST-elevation MI.
* **Elevated troponin I level (3.5 ng/mL)**: While troponin can be elevated in ACS, the level is relatively high, which suggests that there may be more significant cardiac damage.
* **No mention of ECG changes suggestive of ischemia in other leads**: If the patient had unstable angina or non-ST-elevation MI, it would be expected to see ECG changes suggestive of ischemia in other leads.
* **Patient's symptoms are more consistent with an MI**: The patient's symptoms of crushing chest pain radiating to the left arm are more consistent with an MI than with unstable angina or non-ST-elevation MI.","Based on the patient's presentation, laboratory results, and ECG findings, the final diagnosis is:

**Acute Myocardial Infarction (MI), specifically an ST-Elevation Myocardial Infarction (STEMI)**

The diagnosis is supported by the following findings:

* **Elevated troponin I level (3.5 ng/mL)**: This is a specific marker for cardiac damage and is highly suggestive of an MI.
* **ST-segment elevation in leads V2-V4 on the ECG**: This is a classic ECG finding in patients with an STEMI.
* **Crushing chest pain radiating to the left arm**: This is a typical symptom of an MI, particularly if it is severe and persistent.
* **History of hypertension**: Hypertension is a significant risk factor for the development of coronary artery disease, which can lead to an MI.

While the patient's symptoms started after a stressful event, which could suggest Takotsubo cardiomyopathy, the presence of ST-segment elevation and elevated troponin level are more consistent with an MI. Additionally, the patient's age, history of hypertension, and symptoms are all consistent with an MI.

The patient should be managed according to the American College of Cardiology/American Heart Association (ACC/AHA) guidelines for STEMI, which includes immediate activation of the cardiac catheterization laboratory for primary percutaneous coronary intervention (PCI) and administration of aspirin, beta blockers, and other evidence-based therapies as indicated.","Based on the final diagnosis of Acute Myocardial Infarction (MI), specifically an ST-Elevation Myocardial Infarction (STEMI), the following additional steps should be taken:

1. **Activate the cardiac catheterization laboratory for primary percutaneous coronary intervention (PCI)**: The patient should be immediately transferred to the cardiac catheterization laboratory for primary PCI, which involves opening the blocked coronary artery using a balloon and stent.
2. **Administer aspirin and other antiplatelet agents**: The patient should be given aspirin and other antiplatelet agents, such as clopidogrel or prasugrel, to prevent further clotting and reduce the risk of another MI.
3. **Administer beta blockers**: Beta blockers, such as metoprolol or atenolol, should be given to reduce the patient's heart rate and blood pressure, which can help reduce the workload on the heart and decrease the risk of further damage.
4. **Administer nitrates**: Nitrates, such as nitroglycerin, can help dilate the coronary arteries and reduce the patient's blood pressure, which can help improve blood flow to the heart muscle.
5. **Monitor the patient's ECG and vital signs**: The patient's ECG and vital signs should be continuously monitored to assess the effectiveness of treatment and detect any potential complications.
6. **Obtain a chest X-ray**: A chest X-ray should be obtained to assess the patient's lung fields and cardiac silhouette, which can help identify any potential complications, such as pulmonary edema.
7. **Obtain a complete blood count (CBC) and basic metabolic panel (BMP)**: A CBC and BMP should be obtained to assess the patient's overall health and detect any potential electrolyte imbalances or other abnormalities.
8. **Consult with a cardiologist**: A cardiologist should be consulted to assist with the patient's management and to provide guidance on the use of evidence-based therapies, such as anticoagulants and antiplatelet agents.
9. **Consider the use of thrombolytic therapy**: If primary PCI is not available, thrombolytic therapy, such as tissue plasminogen activator (tPA), may be considered to dissolve the clot and restore blood flow to the heart muscle.
10. **Develop a plan for post-MI care**: A plan should be developed for the patient's post-MI care, including follow-up appointments with a cardiologist, medication management, and lifestyle modifications to reduce the risk of another MI.

In terms of specific medications, the following may be considered:

* Aspirin: 162-325 mg orally once
* Clopidogrel: 600 mg orally once, followed by 75 mg orally daily
* Metoprolol: 25-50 mg orally every 6-8 hours
* Nitroglycerin: 0.4 mg sublingually every 5 minutes as needed
* Morphine: 2-4 mg intravenously every 5-10 minutes as needed for pain control

Note: The specific medications and dosages may vary depending on the patient's individual needs and medical history.","{""Score"":3,""Rationale"":""Student listed Acute Myocardial Infarction, Takotsubo Cardiomyopathy (stress‑induced cardiomyopathy) and Unstable Angina, matching all three rubric items.""}","{""Score"":6,""Rationale"":""The answer correctly identifies all three concepts from the rubric: Acute Myocardial Infarction, Takotsubo (Stress‑Induced) Cardiomyopathy, and Unstable Angina (as part of ACS). Each matches a rubric concept, earning the full 2 points per item for a total of 6.""}","{""Score"":0,""Rationale"":""The student's opposing findings do not match any of the concepts listed in the high‑scoring example; therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer identifies an ST-Elevation Myocardial Infarction (STEMI), which matches the high‑scoring example diagnosis of Acute Coronary Syndrome (Anterior STEMI).""}","{""Score"":2,""Rationale"":""The answer includes a referral to a cardiologist, matching one rubric item (2 points). It mentions beta‑blockers but omits ACE inhibitors, and does not include follow‑up echocardiogram or psychological support, so no points for those items.""}",13.0
"History of Present Illness
A 65-year-old male with a history of type 2 diabetes and hypertension presents with a 2-hour history of crushing chest pain radiating to his left arm. He describes the pain as severe and constant, beginning after he climbed a flight of stairs. He is also feeling nauseated and sweaty. He is unable to recall a prior history of similar symptoms. He denies shortness of breath or palpitations but admits to feeling unusually fatigued for the last week.

  Past Medical History
Type 2 diabetes mellitus for 15 years, hypertension for 12 years, and hyperlipidemia. He is on metformin and a statin. He has no history of coronary artery disease or previous myocardial infarctions. He is a smoker (30 pack-years) and drinks alcohol occasionally. Family history is significant for cardiovascular disease, with both parents having had myocardial infarctions in their 50s

  Physical Examination
VITALS: BP 160/90 mmHg, pulse 110 bpm, temperature 98.5°F. 
GEN: Anxious and diaphoretic, in moderate distress due to chest pain. 
CARDIAC: Tachycardic, regular rhythm
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: No tenderness or joint swelling. 
EXT: No edema. 
SKIN: Diaphoretic, cool extremities.

  Laboratory Results
Troponin I: 3.2 ng/mL (elevated). CBC: Normal. Serum glucose: 180 mg/dL (elevated).",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and elevated troponin I level are consistent with an acute MI.
2. **Unstable Angina**: The patient's chest pain and electrocardiogram (ECG) findings (although not provided) may also suggest unstable angina, which is a precursor to an MI.
3. **Acute Coronary Syndrome (ACS)**: This is a broader diagnosis that encompasses both MI and unstable angina, and is characterized by a sudden reduction in blood flow to the heart, leading to chest pain and other symptoms.

Note: Other diagnoses, such as pulmonary embolism or aortic dissection, are less likely given the patient's presentation, but should still be considered in the differential diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* **Chest pain characteristics**: The patient's chest pain is described as crushing, severe, and constant, which is consistent with the typical presentation of an MI.
* **Radiation to left arm**: The radiation of pain to the left arm is a common feature of MI.
* **Elevated troponin I**: The troponin I level of 3.2 ng/mL is elevated, which is a specific marker for cardiac damage and strongly supports the diagnosis of MI.
* **History of hypertension and hyperlipidemia**: These conditions increase the risk of developing atherosclerosis, which can lead to an MI.
* **Smoking history**: The patient's 30 pack-year smoking history is a significant risk factor for cardiovascular disease, including MI.
* **Family history of cardiovascular disease**: The patient's family history of MI in both parents increases his risk of developing cardiovascular disease.

**2. Unstable Angina**

* **Chest pain characteristics**: While the patient's chest pain is severe and constant, it is also triggered by physical activity (climbing stairs), which is consistent with unstable angina.
* **History of hypertension and hyperlipidemia**: These conditions increase the risk of developing atherosclerosis, which can lead to unstable angina.
* **Smoking history**: The patient's smoking history increases his risk of developing cardiovascular disease, including unstable angina.
* **Family history of cardiovascular disease**: The patient's family history of MI in both parents increases his risk of developing cardiovascular disease.
* **Recent fatigue**: The patient's recent fatigue could be a symptom of decreased cardiac output, which can occur in unstable angina.

**3. Acute Coronary Syndrome (ACS)**

* **Chest pain characteristics**: The patient's chest pain is consistent with ACS, which encompasses both MI and unstable angina.
* **Elevated troponin I**: The elevated troponin I level supports the diagnosis of ACS, as it indicates cardiac damage.
* **History of hypertension and hyperlipidemia**: These conditions increase the risk of developing atherosclerosis, which can lead to ACS.
* **Smoking history**: The patient's smoking history increases his risk of developing cardiovascular disease, including ACS.
* **Family history of cardiovascular disease**: The patient's family history of MI in both parents increases his risk of developing cardiovascular disease.
* **Diabetes**: The patient's history of type 2 diabetes mellitus increases his risk of developing cardiovascular disease, including ACS.

Note that the findings and risk factors for ACS are similar to those for MI and unstable angina, as ACS is a broader diagnosis that encompasses both conditions.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* **Absence of shortness of breath**: While the patient is experiencing chest pain and nausea, he does not report shortness of breath, which is a common symptom of MI, particularly if there is associated heart failure or pulmonary edema.
* **Normal pulmonary examination**: The patient's lungs are clear to auscultation, which suggests that there is no significant pulmonary edema or congestion, which can be seen in MI.
* **No reported palpitations**: The patient does not report any palpitations or irregular heart rhythms, which can be seen in MI, particularly if there is associated arrhythmia.
* **No significant ECG changes mentioned**: While the troponin I level is elevated, there is no mention of significant ECG changes, such as ST-segment elevation or Q-waves, which are often seen in MI.

**2. Unstable Angina**

* **Severe and constant chest pain**: The patient's chest pain is described as severe and constant, which is more typical of MI than unstable angina. Unstable angina typically presents with chest pain that is more intermittent and variable in severity.
* **Elevated troponin I**: The elevated troponin I level suggests that there is cardiac damage, which is more consistent with MI than unstable angina. Unstable angina typically does not result in significant cardiac damage or troponin elevation.
* **No reported episodes of chest pain at rest**: The patient's chest pain occurred after physical activity (climbing stairs), but there is no mention of episodes of chest pain at rest, which is a common feature of unstable angina.

**3. Acute Coronary Syndrome (ACS)**

* **Absence of significant ECG changes**: While the troponin I level is elevated, there is no mention of significant ECG changes, such as ST-segment elevation or Q-waves, which are often seen in ACS.
* **No reported episodes of chest pain at rest**: The patient's chest pain occurred after physical activity (climbing stairs), but there is no mention of episodes of chest pain at rest, which is a common feature of ACS.
* **Normal pulmonary examination**: The patient's lungs are clear to auscultation, which suggests that there is no significant pulmonary edema or congestion, which can be seen in ACS.

Note that these opposing findings do not necessarily rule out each diagnosis, but rather suggest that the diagnosis may be more complex or that there may be other factors at play.","Based on the patient's presentation, history, and laboratory results, the final diagnosis is:

**Acute Myocardial Infarction (MI)**, specifically a **Non-ST-Elevation Myocardial Infarction (NSTEMI)**.

The diagnosis is supported by the following key findings:

1. **Chest pain characteristics**: The patient's chest pain is described as crushing, severe, and constant, which is consistent with the typical presentation of an MI.
2. **Elevated troponin I**: The troponin I level of 3.2 ng/mL is elevated, which is a specific marker for cardiac damage and strongly supports the diagnosis of MI.
3. **History of hypertension and hyperlipidemia**: These conditions increase the risk of developing atherosclerosis, which can lead to an MI.
4. **Smoking history**: The patient's 30 pack-year smoking history is a significant risk factor for cardiovascular disease, including MI.
5. **Family history of cardiovascular disease**: The patient's family history of MI in both parents increases his risk of developing cardiovascular disease.

The diagnosis of NSTEMI is specifically supported by the fact that there is no mention of significant ECG changes, such as ST-segment elevation, which would be more consistent with a STEMI (ST-Elevation Myocardial Infarction).

The patient's presentation and laboratory results are consistent with a diagnosis of NSTEMI, and he should be managed accordingly, with immediate initiation of antiplatelet therapy, anticoagulation, and consideration of early invasive strategy with coronary angiography and possible percutaneous coronary intervention (PCI).","Based on the final diagnosis of **Acute Myocardial Infarction (MI)**, specifically a **Non-ST-Elevation Myocardial Infarction (NSTEMI)**, the following additional steps should be taken:

1. **Immediate initiation of antiplatelet therapy**:
	* Aspirin 162-325 mg PO should be administered immediately, unless contraindicated.
	* P2Y12 inhibitor (e.g., clopidogrel, prasugrel, or ticagrelor) should be started as soon as possible, unless contraindicated.
2. **Anticoagulation**:
	* Unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) should be started as soon as possible, unless contraindicated.
3. **Nitrates**:
	* Nitroglycerin should be administered sublingually or intravenously to help relieve chest pain and reduce myocardial oxygen demand.
4. **Beta-blockers**:
	* Beta-blockers (e.g., metoprolol, atenolol) should be started as soon as possible, unless contraindicated, to reduce myocardial oxygen demand and improve survival.
5. **Statins**:
	* The patient is already on a statin, which should be continued to help reduce cholesterol levels and improve outcomes.
6. **Pain management**:
	* Morphine or other opioids should be used to manage chest pain, as needed.
7. **Cardiac monitoring**:
	* The patient should be placed on a cardiac monitor to monitor for arrhythmias and other cardiac complications.
8. **Early invasive strategy**:
	* The patient should be considered for early coronary angiography and possible percutaneous coronary intervention (PCI) within 24 hours of admission, unless contraindicated.
9. **Cardiology consultation**:
	* A cardiologist should be consulted to help manage the patient's care and make decisions regarding further treatment, including potential coronary angiography and PCI.
10. **Risk factor modification**:
	* The patient's risk factors, including hypertension, hyperlipidemia, and smoking, should be addressed and managed to reduce the risk of future cardiovascular events.

Additionally, the following laboratory tests and imaging studies should be ordered:

1. **Serial troponin levels**: To monitor for ongoing cardiac damage.
2. **Complete blood count (CBC)**: To evaluate for anemia or other hematologic abnormalities.
3. **Basic metabolic panel (BMP)**: To evaluate for electrolyte imbalances or renal dysfunction.
4. **Liver function tests (LFTs)**: To evaluate for liver dysfunction.
5. **Chest X-ray**: To evaluate for pulmonary edema or other pulmonary complications.
6. **Echocardiogram**: To evaluate left ventricular function and detect any wall motion abnormalities.

These additional steps will help to optimize the patient's care and improve outcomes following an NSTEMI.","{""Score"":2,""Rationale"":""The answer includes Acute Myocardial Infarction and Unstable Angina, which match two items in the rubric. The third listed diagnosis, Acute Coronary Syndrome, does not match Gastroesophageal Reflux Disease, so no point for that item.""}","{""Score"":4,""Rationale"":""Student correctly identified Acute Myocardial Infarction and Unstable Angina with relevant findings, matching the rubric and earning 2 points each. They omitted the GERD diagnosis required for the third 2‑point item, so no points were awarded for that portion.""}","{""Score"":0,""Rationale"":""Student answer does not match the required opposing findings for Acute MI, Unstable Angina, or GERD as listed in the rubric; it provides different concepts and omits GERD entirely.""}","{""Score"":1,""Rationale"":""The answer includes crushing chest pain, elevated troponin, and risk factors, matching key concepts from the rubric, but omits the ST-segment elevation component required for full credit.""}","{""Score"":6,""Rationale"":""Student includes aspirin and heparin (concept 1), nitroglycerin (concept 2), and early coronary angiography/PCI (concept 3); all three rubric items are present, earning full 6 points.""}",13.0
"History of Present Illness
A 60-year-old male with a recent history of hip replacement surgery 2 weeks ago presents with sudden onset of shortness of breath and pleuritic chest pain. The pain is sharp and worsens with deep breathing or coughing. He has been feeling progressively more breathless, even while at rest, and also reports a mild cough. He denies fever or hemoptysis but admits to feeling fatigued and dizzy on exertion. He has not been able to move around much post-surgery, and has been primarily confined to bed. He has no known history of deep vein thrombosis (DVT).

  Past Medical History
He has a history of osteoarthritis, for which he underwent the recent hip replacement. He has no known history of cardiovascular or respiratory disease. No significant family history of pulmonary embolism or clotting disorders. He is a non-smoker and does not drink alcohol.

  Physical Examination
VITALS: BP 130/85 mmHg, pulse 110 bpm, temperature 98.7°F, respiratory rate 22/min. GEN: Mildly anxious, appears in moderate distress due to breathing difficulties. CARDIAC: Tachycardic, regular rhythm, no murmurs. 
PULM: Tachypneic, decreased breath sounds at the right base, no wheezing. 
ABD: Soft, non-tender. 
MSK: Limited movement of the right hip due to recent surgery. 
EXT: Mild swelling in the right lower leg, no redness or warmth. 
SKIN: No rashes, warm extremities.

  Laboratory Results
D-dimer: 8.5 µg/mL (elevated). Chest CT angiogram: Acute pulmonary embolism in the right lower lobe pulmonary artery. ABG: pO2 70 mmHg, pCO2 35 mmHg.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Pulmonary Embolism (PE)**: The patient's symptoms of sudden onset shortness of breath, pleuritic chest pain, and elevated D-dimer, along with the chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery, strongly support this diagnosis.
2. **Deep Vein Thrombosis (DVT)**: The patient's recent history of hip replacement surgery, immobility, and mild swelling in the right lower leg suggest a possible DVT, which could be a source of the pulmonary embolism.
3. **Pneumonia**: Although the patient denies fever and hemoptysis, the symptoms of shortness of breath, pleuritic chest pain, and decreased breath sounds at the right base could also be consistent with pneumonia, particularly if the pulmonary embolism has caused infarction of the lung tissue. However, the chest CT angiogram and laboratory results make PE a more likely diagnosis.","Here are the findings and risk factors supporting each possible diagnosis:

**1. Pulmonary Embolism (PE)**

* Supporting findings:
	+ Sudden onset of shortness of breath and pleuritic chest pain
	+ Elevated D-dimer (8.5 µg/mL)
	+ Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
	+ Decreased breath sounds at the right base on physical examination
	+ Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of venous thromboembolism (VTE)
	+ Immobility post-surgery, which increases the risk of VTE
	+ Age (60 years), which is a risk factor for VTE

**2. Deep Vein Thrombosis (DVT)**

* Supporting findings:
	+ Mild swelling in the right lower leg
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility post-surgery, which increases the risk of VTE
* Risk factors:
	+ Recent hip replacement surgery, which increases the risk of VTE
	+ Immobility post-surgery, which increases the risk of VTE
	+ Age (60 years), which is a risk factor for VTE
	+ Note: While there is no known history of DVT, the patient's recent surgery and immobility increase the risk of developing a DVT

**3. Pneumonia**

* Supporting findings:
	+ Shortness of breath and pleuritic chest pain
	+ Decreased breath sounds at the right base on physical examination
	+ Mild cough
* Risk factors:
	+ Recent surgery, which can increase the risk of respiratory complications
	+ Age (60 years), which can increase the risk of pneumonia
	+ However, the lack of fever, hemoptysis, and other typical symptoms of pneumonia, as well as the presence of a clear alternative diagnosis (PE), make this diagnosis less likely.","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Pulmonary Embolism (PE)**

* Opposing findings:
	+ The patient's oxygen saturation is not severely impaired (pO2 70 mmHg), which might be expected in a larger or more central PE.
	+ The patient does not have a history of DVT or known risk factors for thrombophilia, although the recent surgery and immobility are significant risk factors.
	+ The patient's blood pressure is relatively stable (BP 130/85 mmHg), which might not be expected in a large or saddle PE.
* Expected findings that are not present:
	+ Hemoptysis, which can occur in up to 20% of patients with PE, but is not present in this case.
	+ Syncope, which can occur in patients with large or saddle PEs, but is not reported in this case.
	+ A more significant drop in oxygen saturation, which might be expected in a larger or more central PE.

**2. Deep Vein Thrombosis (DVT)**

* Opposing findings:
	+ The patient does not have significant swelling, redness, or warmth in the affected leg, which are common symptoms of DVT.
	+ The patient does not have a history of DVT or known risk factors for thrombophilia, although the recent surgery and immobility are significant risk factors.
	+ The patient's symptoms are more consistent with a pulmonary issue (shortness of breath, pleuritic chest pain) rather than a lower extremity issue.
* Expected findings that are not present:
	+ Significant leg swelling, which is a common symptom of DVT.
	+ Redness or warmth in the affected leg, which can occur in DVT.
	+ A palpable cord or tenderness along the vein, which can occur in DVT.

**3. Pneumonia**

* Opposing findings:
	+ The patient does not have a fever, which is a common symptom of pneumonia.
	+ The patient does not have a productive cough or hemoptysis, which can occur in pneumonia.
	+ The chest CT angiogram shows a pulmonary embolism, which is not consistent with pneumonia.
* Expected findings that are not present:
	+ Fever, which is a common symptom of pneumonia.
	+ Productive cough or hemoptysis, which can occur in pneumonia.
	+ Crackles or wheezing on lung exam, which can occur in pneumonia.
	+ A higher white blood cell count or other signs of infection, which are not reported in this case.","Based on the patient's presentation, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Acute Pulmonary Embolism (PE)**

The diagnosis is supported by:

* Sudden onset of shortness of breath and pleuritic chest pain
* Elevated D-dimer (8.5 µg/mL)
* Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
* Decreased breath sounds at the right base on physical examination
* Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)
* Recent hip replacement surgery and immobility, which are significant risk factors for venous thromboembolism (VTE)

The patient's symptoms and laboratory results are consistent with an acute PE, and the chest CT angiogram provides definitive evidence of the diagnosis. The patient's recent surgery and immobility increase the risk of VTE, and the presence of a DVT in the right lower leg (suggested by mild swelling) may be the source of the PE.

Treatment for the patient should include:

* Anticoagulation therapy to prevent further clot formation and extension of the existing clot
* Oxygen therapy to improve oxygen saturation
* Pain management for pleuritic chest pain
* Monitoring for signs of hemodynamic instability or other complications
* Consideration of thrombolytic therapy or other interventions if the patient's condition worsens or if there are signs of hemodynamic instability.","Based on the final diagnosis of Acute Pulmonary Embolism (PE), the following additional steps should be taken:

1. **Initiate Anticoagulation Therapy**: Start the patient on anticoagulation therapy with a low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) to prevent further clot formation and extension of the existing clot.
2. **Order Additional Laboratory Tests**: Order additional laboratory tests, such as:
	* Complete Blood Count (CBC) to evaluate for signs of infection or inflammation
	* Blood chemistry tests to evaluate for signs of kidney or liver dysfunction
	* Troponin levels to evaluate for signs of cardiac injury
3. **Perform a Lower Extremity Doppler Ultrasound**: Perform a lower extremity Doppler ultrasound to evaluate for the presence of a Deep Vein Thrombosis (DVT) in the right lower leg, which may be the source of the PE.
4. **Consult a Pulmonologist or Cardiologist**: Consult a pulmonologist or cardiologist to assist with management of the patient's PE and to evaluate for any underlying conditions that may have contributed to the development of the PE.
5. **Monitor for Signs of Hemodynamic Instability**: Closely monitor the patient for signs of hemodynamic instability, such as:
	* Hypotension
	* Tachycardia
	* Decreased oxygen saturation
	* Increased respiratory rate
6. **Consider Thrombolytic Therapy**: Consider thrombolytic therapy if the patient's condition worsens or if there are signs of hemodynamic instability.
7. **Order an Echocardiogram**: Order an echocardiogram to evaluate for signs of right ventricular dysfunction, which can occur in patients with large or massive PEs.
8. **Develop a Plan for Long-Term Anticoagulation**: Develop a plan for long-term anticoagulation therapy, including the use of warfarin or a direct oral anticoagulant (DOAC), to prevent recurrent VTE.
9. **Provide Patient Education**: Provide patient education on the signs and symptoms of PE and DVT, as well as the importance of anticoagulation therapy and follow-up care.
10. **Consider a VTE Prophylaxis Plan**: Consider a VTE prophylaxis plan for the patient, including the use of mechanical prophylaxis (such as compression stockings or intermittent pneumatic compression devices) and pharmacologic prophylaxis (such as LMWH or UFH), to prevent recurrent VTE.","{""Score"":3,""Rationale"":""Student listed Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), and Pneumonia, matching all three concepts in the rubric.""}","{""Score"":6,""Rationale"":""The answer includes all key concepts for PE (sudden SOB, pleuritic pain, elevated D‑dimer, CT confirmation, recent hip surgery, immobility, tachypnea), for Pneumonia (cough, pleuritic pain, lack of fever) and for DVT (leg swelling, recent surgery, immobility), matching the high‑scoring example for each category.""}","{
  ""Score"": 4,
  ""Rationale"": ""The answer correctly identifies opposing findings for Pneumonia (absence of fever) and DVT (no redness, warmth, or prior DVT), matching concepts in the rubric, earning 2 points each. However, for Pulmonary Embolism the rubric expects no opposing findings, while the answer lists several opposing findings, which does not match the high-scoring example, resulting in 0 points for PE.""
}","{""Score"":2,""Rationale"":""The answer identifies Pulmonary Embolism and provides the same key supporting details as the high‑scoring example (sudden shortness of breath, pleuritic chest pain, elevated D‑dimer, and CT angiogram confirmation), thus meeting all rubric criteria for full credit.""}","{""Score"":4,""Rationale"":""The answer includes Anticoagulation and a Lower Extremity Ultrasound for DVT evaluation, matching two rubric items (2 points each). It does not mention Oxygen therapy, so no points for that item.""}",19.0
"History of Present Illness
A 74-year-old female presents with a 1-month history of progressive fatigue, dizziness, and pale appearance. Over the last two weeks, she has noticed intermittent black, tarry stools and occasional bright red blood after bowel movements. She denies significant abdominal pain, nausea, or vomiting but mentions a history of occasional heartburn, which she manages with over-the-counter antacids. She has no history of hemorrhoids or significant gastrointestinal issues. She does not recall recent weight loss, but reports feeling more fatigued than usual.

  Past Medical History
She has a history of hypertension, controlled with an angiotensin II receptor blocker, and osteoarthritis. She is a former smoker (quit 10 years ago) and consumes alcohol occasionally. No family history of gastrointestinal cancers or bleeding disorders.

  Physical Examination
VITALS: BP 110/70 mmHg, pulse 88 bpm, temperature 98.2°F. 
GEN: Pale and fatigued-appearing. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild epigastric tenderness, no hepatosplenomegaly. No rebound tenderness or guarding. 
EXT: No edema, peripheral pulses intact. 
SKIN: Pale conjunctiva, no jaundice.

  Laboratory Results
Hemoglobin: 8.9 g/dL (low). Hematocrit: 27% (low). Platelets: 150 x 10^3/μL. Fecal occult blood test: Positive. Colonoscopy: Findings of multiple diverticula with no active bleeding. No masses or polyps observed.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation, here are 3 possible diagnoses:

1. **Diverticular Disease with Chronic Bleeding**: The patient's colonoscopy showed multiple diverticula, which can cause chronic, intermittent bleeding leading to iron deficiency anemia, as evidenced by her low hemoglobin and hematocrit levels.
2. **Gastrointestinal Angiodysplasia**: This condition involves abnormal blood vessels in the gastrointestinal tract that can cause chronic, occult bleeding. The patient's age and lack of other obvious sources of bleeding make this a possible diagnosis.
3. **Upper Gastrointestinal Bleeding (likely from gastric or duodenal ulcers)**: The patient's history of occasional heartburn and use of antacids, combined with her symptoms of black, tarry stools (melena) and bright red blood per rectum, suggest the possibility of an upper GI bleed, potentially from a gastric or duodenal ulcer. The absence of significant abdominal pain does not rule out this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Diverticular Disease with Chronic Bleeding**

* Supportive findings:
	+ Colonoscopy showing multiple diverticula
	+ Positive fecal occult blood test (FOBT)
	+ Intermittent black, tarry stools (melena) and bright red blood per rectum, suggesting chronic, intermittent bleeding
* Risk factors:
	+ Age (74 years): Diverticular disease is more common in older adults
	+ Lack of significant abdominal pain: Diverticular bleeding can be painless

**2. Gastrointestinal Angiodysplasia**

* Supportive findings:
	+ Age (74 years): Angiodysplasia is more common in older adults
	+ Chronic, intermittent bleeding (suggested by intermittent melena and bright red blood per rectum)
	+ Low hemoglobin and hematocrit levels, indicating chronic blood loss
* Risk factors:
	+ Age (74 years): As mentioned earlier, angiodysplasia is more common in older adults
	+ Former smoker: Smoking is a risk factor for angiodysplasia
	+ Hypertension: Some studies suggest a link between hypertension and angiodysplasia

**3. Upper Gastrointestinal Bleeding (likely from gastric or duodenal ulcers)**

* Supportive findings:
	+ History of occasional heartburn, suggesting gastroesophageal reflux disease (GERD)
	+ Use of antacids, which may indicate underlying acid-peptic disease
	+ Black, tarry stools (melena), which can indicate upper GI bleeding
* Risk factors:
	+ Age (74 years): The risk of peptic ulcer disease increases with age
	+ Former smoker: Smoking is a risk factor for peptic ulcer disease
	+ Use of antacids, which may indicate underlying acid-peptic disease
	+ Hypertension: Some studies suggest a link between hypertension and peptic ulcer disease

Note that these findings and risk factors are not mutually exclusive, and some may support multiple possible diagnoses. Further evaluation and testing may be necessary to confirm the diagnosis.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Diverticular Disease with Chronic Bleeding**

* Opposing findings:
	+ No active bleeding was seen on colonoscopy, which might be expected if diverticular disease was the primary cause of bleeding
	+ The patient's symptoms of bright red blood per rectum are not typical of diverticular bleeding, which usually presents with melena (black, tarry stools)
* Expected but not present:
	+ Left lower quadrant abdominal pain, which is a common symptom of diverticular disease
	+ Significant abdominal tenderness on physical examination, which might be expected if diverticular disease was causing significant bleeding or inflammation

**2. Gastrointestinal Angiodysplasia**

* Opposing findings:
	+ The patient's colonoscopy did not show any evidence of angiodysplasia, which is typically characterized by the presence of ectatic, thin-walled blood vessels in the colon
	+ The patient's bleeding pattern is not typical of angiodysplasia, which usually presents with chronic, occult bleeding rather than intermittent melena and bright red blood per rectum
* Expected but not present:
	+ A history of aortic stenosis or other cardiovascular disease, which is sometimes associated with angiodysplasia
	+ Evidence of chronic kidney disease, which can increase the risk of angiodysplasia

**3. Upper Gastrointestinal Bleeding (likely from gastric or duodenal ulcers)**

* Opposing findings:
	+ The patient's colonoscopy did not show any evidence of a source of upper GI bleeding, such as a bleeding ulcer or varices
	+ The patient's symptoms of bright red blood per rectum are not typical of upper GI bleeding, which usually presents with melena (black, tarry stools)
* Expected but not present:
	+ Significant epigastric tenderness on physical examination, which might be expected if the patient had a bleeding peptic ulcer
	+ A history of nonsteroidal anti-inflammatory drug (NSAID) use, which can increase the risk of peptic ulcer disease
	+ Evidence of hematemesis (vomiting blood), which can occur with upper GI bleeding

Note that the absence of certain findings or symptoms does not necessarily rule out a particular diagnosis, and further evaluation and testing may be necessary to confirm or exclude each possible diagnosis.","Based on the patient's presentation, laboratory results, and colonoscopy findings, the final diagnosis is:

**Diverticular Disease with Chronic Bleeding**

Although the colonoscopy did not show active bleeding, the presence of multiple diverticula and the patient's symptoms of intermittent melena and bright red blood per rectum, along with the positive fecal occult blood test, suggest that the diverticula are the likely source of the chronic bleeding. The patient's age, lack of significant abdominal pain, and low hemoglobin and hematocrit levels also support this diagnosis.

The fact that the colonoscopy did not show any other obvious sources of bleeding, such as ulcers or angiodysplasia, and the patient's symptoms are consistent with chronic, intermittent bleeding, makes diverticular disease with chronic bleeding the most likely diagnosis.

**Recommendations:**

* Iron supplementation to treat the patient's iron deficiency anemia
* Consideration of colonoscopy with clipping or cauterization of the bleeding diverticula if the bleeding persists or worsens
* Monitoring of the patient's hemoglobin and hematocrit levels to assess the effectiveness of treatment
* Consideration of other diagnostic tests, such as a upper endoscopy, if the patient's symptoms persist or worsen, to rule out other sources of bleeding.","Based on the final diagnosis of Diverticular Disease with Chronic Bleeding, the following additional steps can be taken:

1. **Iron Supplementation**: Prescribe oral iron supplements to treat the patient's iron deficiency anemia. Monitor the patient's hemoglobin and hematocrit levels regularly to assess the effectiveness of treatment.
2. **Colonoscopy with Clipping or Cauterization**: Consider repeating the colonoscopy with clipping or cauterization of the bleeding diverticula if the bleeding persists or worsens. This can help to control the bleeding and prevent further anemia.
3. **Upper Endoscopy**: Consider performing an upper endoscopy to rule out any other sources of bleeding in the upper gastrointestinal tract, such as ulcers or varices.
4. **Blood Transfusion**: If the patient's anemia is severe, consider a blood transfusion to rapidly improve the patient's hemoglobin and hematocrit levels.
5. **Monitoring**: Regularly monitor the patient's vital signs, including blood pressure, pulse, and oxygen saturation, to ensure that the patient is stable and not experiencing any further bleeding.
6. **Follow-up Appointments**: Schedule follow-up appointments with the patient to monitor their condition, adjust treatment as needed, and assess the effectiveness of treatment.
7. **Lifestyle Modifications**: Advise the patient to make lifestyle modifications to reduce the risk of further bleeding, such as:
	* Increasing fiber intake to reduce the risk of constipation and straining during bowel movements
	* Avoiding heavy lifting or straining
	* Avoiding NSAIDs and other medications that can increase the risk of bleeding
8. **Consideration of Other Tests**: Consider ordering other tests, such as:
	* Complete Blood Count (CBC) to monitor the patient's blood cell counts
	* Electrolyte panel to monitor the patient's electrolyte levels
	* Liver function tests to monitor the patient's liver function
9. **Referral to a Specialist**: If the patient's condition is complex or if the bleeding is severe, consider referring the patient to a gastroenterologist or a surgeon for further evaluation and treatment.
10. **Patient Education**: Educate the patient on the importance of follow-up appointments, medication adherence, and lifestyle modifications to reduce the risk of further bleeding and improve overall health.","{""Score"":1,""Rationale"":""The answer includes Upper GI Bleeding likely from gastric/duodenal ulcer, matching the rubric's Peptic Ulcer Disease with Upper GI Bleeding. It does not mention Gastritis with Chronic GI Bleeding or Gastrointestinal Malignancy, so only 1 point is awarded.""}","{""Score"":2,""Rationale"":""The answer includes a diagnosis of upper gastrointestinal bleeding/peptic ulcer disease, which matches a concept in the rubric (Peptic Ulcer Disease). The other two diagnoses (Diverticular Disease and Angiodysplasia) are not listed in the rubric, so no points are awarded for them.""}","{""Score"":2,""Rationale"":""The answer only includes the concept of no NSAID use related to peptic ulcer disease, matching one of the three rubric items; it does not address the gastritis endoscopic confirmation or gastrointestinal malignancy criteria, so only 2 of 6 points are earned.""}","{
  ""Score"": 0,
  ""Rationale"": ""The answer does not match the high scoring example; it lacks the required heartburn history and proposes a different diagnosis (diverticular disease) not listed in the rubric, resulting in zero points.""
}","{""Score"":4,""Rationale"":""The answer includes Upper Endoscopy and monitoring hemoglobin with consideration of blood transfusion, matching two rubric items. It does not mention starting PPI therapy or assessing/treating Helicobacter pylori, so those points are not awarded.""}",9.0
,,,,,,,,,,,,,,,,
